NO790568L - PROCEDURE FOR THE PREPARATION OF HALOGEN-SUBSTITUTED MARKAPTOACYLAMINO ACIDS - Google Patents

PROCEDURE FOR THE PREPARATION OF HALOGEN-SUBSTITUTED MARKAPTOACYLAMINO ACIDS

Info

Publication number
NO790568L
NO790568L NO790568A NO790568A NO790568L NO 790568 L NO790568 L NO 790568L NO 790568 A NO790568 A NO 790568A NO 790568 A NO790568 A NO 790568A NO 790568 L NO790568 L NO 790568L
Authority
NO
Norway
Prior art keywords
hydrogen
proline
acid
halogen
product
Prior art date
Application number
NO790568A
Other languages
Norwegian (no)
Inventor
Miguel A Ondetti
Peter W Sprague
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/939,147 external-priority patent/US4154935A/en
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of NO790568L publication Critical patent/NO790568L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Description

"Fremgangsmåte for fremstilling av halogen-substituerte merkaptoacylaminosyrer" "Procedure for the production of halogen-substituted mercaptoacyl amino acids"

Denne oppfinnelse angår fremstilling av nye halogenerte forbindelser med den generelle formel This invention relates to the preparation of new halogenated compounds with the general formula

(I) (IN)

hvor R er hydrogen, lavere alkanoyl eller where R is hydrogen, lower alkanoyl or

m er 1 eller 2; n er 0 eller 1 m is 1 or 2; n is 0 or 1

R^er hydrogen eller , lavere alkyl; R 1 is hydrogen or , lower alkyl;

R2og R'2 er hver hydrogen eller halogenjR 2 and R 2 are each hydrogen or halogen

R^er hydrogen, lavere alkyl eller CF^ og også halogen når n er 1; R^er hydrogen, lavere alkyl eller trifluormetyl; R^ is hydrogen, lower alkyl or CF^ and also halogen when n is 1; R 1 is hydrogen, lower alkyl or trifluoromethyl;

Rg er hydrogen og også halogen når m er 1; Rg is hydrogen and also halogen when m is 1;

idet minst én av R„, R' , R0, R. og R, er halogen eller CF_ som representert ved symbolene, og bare R2og R'2 kan begge være halogen samtidig. wherein at least one of R„, R', R0, R. and R, is halogen or CF_ as represented by the symbols, and only R.sub.2 and R.sub.2 can both be halogen at the same time.

Stjernen.betegner et asymmetrisk karbonatom.The star denotes an asymmetric carbon atom.

Oppfinnelsen angår således generelt halogenerte derivater av merkaptoacylprolin og merkaptoacylpipekolsyre med formel I. The invention thus generally relates to halogenated derivatives of mercaptoacylproline and mercaptoacylpipecolic acid of formula I.

Når det gjelder prolinene (hvor m er 1), er to foretrukne grupper av forbindelser med formel I de som har de følgende formler: Regarding the prolines (where m is 1), two preferred groups of compounds of formula I are those having the following formulas:

(II) (II)

hvor R er hydrogen, lavere alkanoyl eller where R is hydrogen, lower alkanoyl or

R-^ er hydrogen eller lavere alkyl; R 1 is hydrogen or lower alkyl;

R2og R,, er hver hydrogen eller fluor; R 2 and R 1 are each hydrogen or fluorine;

R^og R^er hver hydrogen eller trifluormetyl, idet en er hydrogen og den annen trifluormetyl; og R 1 and R 2 are each hydrogen or trifluoromethyl, one being hydrogen and the other trifluoromethyl; and

n er 0 eller 1; n is 0 or 1;

(III) (III)

hvor R og R^ har samme betydning som angitt ovenfor for formel II; where R and R^ have the same meaning as stated above for formula II;

R2og R,- er hver hydrogen eller halogen; R 2 and R 1 - are each hydrogen or halogen;

R^er hydrogen, halogen eller lavere alkyl, idet R^ er halogen når både R2og R,, er hydrogen, og R^ er forskjellig fra halogen når R2eller R,- er halogen; R^ is hydrogen, halogen or lower alkyl, R^ being halogen when both R 2 and R 1 are hydrogen, and R^ being different from halogen when R 2 or R 1 - is halogen;

R4er hydrogen; ogR 4 is hydrogen; and

n er 0 eller 1; n is 0 or 1;

og basiske salter av nevnte forbindelser med henholdsvis formel II og III. and basic salts of said compounds of formulas II and III, respectively.

Når således n er 0 og og begge er hydrogen iThus when n is 0 and and both are hydrogen i

formel II, er R^ trifluormetyl. Når n er 1, er enten R^ eller R^trifluormetyl og den annen hydrogen. Det betyr at det er én trifluormetylgruppe på acy1-sidekjeden i molekylet. Den er på karbonatomet i a-stilling til karbonylgruppen (R^ = CF^) når n er 0. Den er på enten karbonatomet i a-stilling til karbonylgruppen formula II, R 1 is trifluoromethyl. When n is 1, either R 1 or R 2 is trifluoromethyl and the other is hydrogen. This means that there is one trifluoromethyl group on the acy1 side chain in the molecule. It is on the carbon atom in the a position of the carbonyl group (R^ = CF^) when n is 0. It is on either the carbon atom in the a position of the carbonyl group

(R^= CF^, R4 = H) eller på karbonatomet i p-stilling til karbonylgruppen (R^ = H>R^= CF^) når n er 1, idet den annen av de to symboler (R^, R^) da er' hydrogen. Når enten R^ eller R^ er trifluormetyl, er R£og R,, hver hydrogen eller halogen. (R^= CF^, R4 = H) or on the carbon atom in the p-position to the carbonyl group (R^ = H>R^= CF^) when n is 1, the other of the two symbols (R^, R^ ) then' is hydrogen. When either R₁ or R₁ is trifluoromethyl, R₁ and R₁ are each hydrogen or halogen.

Når det gjelder formel III er fortrinnsvis en av eller både R2og R,- halogen, og R^ og R^er hver hydrogen eller lavere alkyl, eller både R2og Rj. er hydrogen, R^ er halogen, fortrinnsvis klor eller brom, dg R^er hydrogen. In the case of formula III, preferably one of or both R 2 and R 1 are halogen, and R 2 and R 3 are each hydrogen or lower alkyl, or both R 2 and R 1 . is hydrogen, R^ is halogen, preferably chlorine or bromine, dg R^ is hydrogen.

Spesielt foretrekkes de forbindelser med formel I hvorParticularly preferred are those compounds of formula I where

R er hydrogen eller lavere alkanoyl, særlig hydrogen eller acetyl; er hydrogen eller lavere alkyl, særlig hydrogen; R2og R,, ér hver hydrogen eller halogen, særlig hydrogen eller fluor; R is hydrogen or lower alkanoyl, especially hydrogen or acetyl; is hydrogen or lower alkyl, especially hydrogen; R 2 and R 1 are each hydrogen or halogen, especially hydrogen or fluorine;

R^og R^er hver hydrogen, trifluormetyl eller lavere alkyl, idet en av R^ eller R^er trifluormetyl og den annen hydrogen når R2, R^og Rg alle er hydrogen; og n er 0 eller 1, særlig 1. R₂ and R₂ are each hydrogen, trifluoromethyl or lower alkyl, one of R₂ or R₂ being trifluoromethyl and the other hydrogen when R₂, R₂ and R₂ are all hydrogen; and n is 0 or 1, especially 1.

,Ett eller to halogénatomer kan være til stede på pyrrolidinringen. Et enkelt halogenatom kan være på enten karbonatomet i 3-stilling eller på karbonatomet i 4-stilling. ,One or two halogen atoms may be present on the pyrrolidine ring. A single halogen atom can be on either the carbon atom in the 3-position or on the carbon atom in the 4-position.

To halogénatomer kan være til stede i 4-stillingen, og fortrinnsvis er de like. Fluor foretrekkes på denne ring, særlig ett eller to fluoratomer på karbonatomet i 4-stilling. Two halogen atoms may be present in the 4-position, and preferably they are equal. Fluorine is preferred on this ring, especially one or two fluorine atoms on the carbon atom in the 4-position.

Når det gjelder pipekolsyrer (m er 2), foretrekkes de forbindelser, med formel I hvor R er hydrogen eller lavere alkanoyl, særlig hydrogen eller acetyl; R^er hydrogen eller lavere alkyl, særlig hydrogen; R2og R'^er hver hydrogen eller halogen, særlig hydrogen eller fluor; én av R^ og R^er CF^ og den annen er hydrogen; n er 0 eller 1, særlig 1. L og R'2kan uavhengig av hverandre være hydrogen eller halogen, særlig fluor. Når R^ eller R 4 er CF^, er både R2og R'2fortrinnsvis hydrogen. L-konfigurasjonen for prolinene eller pipekolsyrene er særlig foretrukket. In the case of pipecolic acids (m is 2), those compounds of formula I where R is hydrogen or lower alkanoyl, especially hydrogen or acetyl; R 1 is hydrogen or lower alkyl, especially hydrogen; R 2 and R 1 are each hydrogen or halogen, especially hydrogen or fluorine; one of R^ and R^ is CF^ and the other is hydrogen; n is 0 or 1, especially 1. L and R'2 can independently be hydrogen or halogen, especially fluorine. When R 1 or R 4 is CF 2 , both R 2 and R 2 are preferably hydrogen. The L-configuration for the prolines or pipecholic acids is particularly preferred.

De lavere alkylgrupper betegnet med én hvilken som helst av de variable, omfatter lineære og forgrenede hydrokarbon-radikaler fra metyl til heptyl, f.eks. metyl, etyl, propyl, isopropyl, butyl, isobutyl, t-butyl, pentyl, isopentyl og lignende. C^-C^-gruppene, særlig C, og C2~gruppene foretrekkes. The lower alkyl groups denoted by any of the variables include linear and branched hydrocarbon radicals from methyl to heptyl, e.g. methyl, ethyl, propyl, isopropyl, butyl, isobutyl, t-butyl, pentyl, isopentyl and the like. The C^-C^ groups, especially C, and the C2~ groups are preferred.

De lavere alkanoylgrupper er de som har acylradikaler av de lavere { C^- C^) fettsyrer, f.eks. acetyl, propionyl, butyryl og lignende. Tilsvarende foretrekkes de lavere alkanoy1-grupper som har opptil 4 karbonatomer, særlig acetyl. The lower alkanoyl groups are those which have acyl radicals of the lower {C^-C^) fatty acids, e.g. acetyl, propionyl, butyryl and the like. Correspondingly, the lower alkanoyl groups which have up to 4 carbon atoms, especially acetyl, are preferred.

Halogenene er de fire vanlige halogener, fortrinnsvis The halogens are the four common halogens, preferably

klor, brom eller fluor, særlig fluor.chlorine, bromine or fluorine, especially fluorine.

Forbindelsene med formel I fremstilles i henhold til The compounds of formula I are prepared according to

oppfinnelsen ved flere syntesemetoder.the invention by several synthesis methods.

Generelt kan disse forbindelser syntetiseres ved at syren med formelen In general, these compounds can be synthesized by the acid with the formula

kobles til aminosyren med formelen: is connected to the amino acid with the formula:

ved en hvilken som helst metode som kan anvendes for å danne amidbindinger. Se f.eks. "Methoden der Organischen Chemie" by any method that can be used to form amide bonds. See e.g. "The Method of Organic Chemistry"

(Houben-Weyl), del I, side 376 og videre, del III, side 1 og videre (1974) .. (Houben-Weyl), Part I, page 376 et seq., Part III, page 1 et seq. (1974) ..

Syrene med formel IV kan når n er 1 fremstilles ved å sette en tiosyre R-SH til en passende substituert akrylsyre. The acids of formula IV can, when n is 1, be prepared by adding a thioacid R-SH to a suitably substituted acrylic acid.

Som en midlertidig beskyttelse av merkaptogruppen i forbindelsene med formel IV, kan R være en p-metoksy-benzylgruppe. Denne gruppe fjernes derefter med trifluoreddiksyre og kvikksølv(II)acetat. Syrene med formel IV, når n er 0, erholdes ved en fortrengningsreaksjon under anvendelse av en tiosyre R-SH og en 2-halogensyre. As a temporary protection of the mercapto group in the compounds of formula IV, R may be a p-methoxy-benzyl group. This group is then removed with trifluoroacetic acid and mercury(II) acetate. The acids of formula IV, when n is 0, are obtained by a displacement reaction using a thioacid R-SH and a 2-haloacid.

I henhold til en fremgangsmåte som foretrekkes når n er 0, kobles en syre med formel V til en halogenalkansyre med formelen According to a preferred method when n is 0, an acid of formula V is coupled to a haloalkanoic acid of the formula

hvor X er halogen, fortrinnsvis klor eller brom, ved en av de kjente metoder hvor syren VI er aktivert før omsetning med syren V, som omfatter dannelse av et blandet anhydrid, symmetrisk anhydrid, syreklorid, aktiv ester, eller anvendelse av Woodward-reagens K, EEDQ (N-etoksy-karbonyl-2-etoksy-l,2-dihydrokinolin) eller lignende. where X is halogen, preferably chlorine or bromine, by one of the known methods where the acid VI is activated before reaction with the acid V, which includes the formation of a mixed anhydride, symmetrical anhydride, acid chloride, active ester, or the use of Woodward's reagent K , EEDQ (N-ethoxy-carbonyl-2-ethoxy-1,2-dihydroquinoline) or the like.

Produktet som oppnås ved denne omsetning, er en forbindelse med formelen: The product obtained by this reaction is a compound with the formula:

Dette produkt underkastes en fortrengningsreaksjon med anionet av en tiosyre med formelen This product is subjected to a displacement reaction with the anion of a thioacid of the formula

(VIII) (VIII)

R7- CO SHR7- CO SH

hvor R_ er lavere alkyl, hvorved man får et produkt med formelen where R_ is lower alkyl, whereby a product with the formula is obtained

som derefter kan omdannes til produktet: which can then be converted into the product:

ved vanlig alkalisk hydrolyse eller ammonolyse. Når R, er en estergruppe (dvs. R^er lavere alkyl, erholdt når en ester av utgangssyren V anvendes), kan estergruppen fjernes på vanlig måte. Når f.eks. R^ er tert-butoksy eller tert-amyloksy, vil behandling av esteren med formel IX eller X med trifluoreddiksyre og anisol gi den tilsvarende frie syre. Når andre alkoksygrupper er til by ordinary alkaline hydrolysis or ammonolysis. When R 1 is an ester group (ie R 1 is lower alkyl, obtained when an ester of the starting acid V is used), the ester group can be removed in the usual way. When e.g. R^ is tert-butoxy or tert-amyloxy, treatment of the ester of formula IX or X with trifluoroacetic acid and anisole will give the corresponding free acid. When other alkoxy groups are present

stede, vil alkalisk hydrolyse gi den tilsvarende syre.present, alkaline hydrolysis will yield the corresponding acid.

Når en syre med formel V anvendes som utgangsmateriale eller sluttproduktet erholdes som den frie karboksylsyre, kan denne syre omdannes til sin ester, f.eks. ved forestring med et diazoalkan, så som diazometan, l-alkyl-3-p-.toly 1-triazen, When an acid of formula V is used as starting material or the end product is obtained as the free carboxylic acid, this acid can be converted to its ester, e.g. by esterification with a diazoalkane, such as diazomethane, 1-alkyl-3-p-tolyl 1-triazene,

så som l-n-butyl-3-p-tolyltriazen eller lignende.such as 1-n-butyl-3-p-tolyltriazene or the like.

I henhold til en annen variasjon behandles en ester, fortrinnsvis metyl eller t-butylesteren, med formel V i et vannfritt medium så som diklormetan, tetrahydrofuran, dioksan eller lignende, med en acyltioalkansyre med formelen: According to another variation, an ester, preferably the methyl or the t-butyl ester, of formula V is treated in an anhydrous medium such as dichloromethane, tetrahydrofuran, dioxane or the like, with an acylthioalkanoic acid of the formula:

i nærvær av dicykloheksylkarbodiimid, N,N1-karbonylbisimidazol, etoksyacetylen, difenylfosforylazid eller lignende koblingsmidler ved en temperatur i området fra ca. 0 til 10°C. Estergruppen kan derefter fjernes, f.eks. ved behandling med trifluoreddiksyre og anisol ved omtrentlig romtemperatur for å gi den frie syre in the presence of dicyclohexylcarbodiimide, N,N1-carbonylbisimidazole, ethoxyacetylene, diphenylphosphorylazide or similar coupling agents at a temperature in the range from approx. 0 to 10°C. The ester group can then be removed, e.g. by treatment with trifluoroacetic acid and anisole at about room temperature to give the free acid

(R-L = H) .(R-L = H) .

En variasjon, som foretrekkes når n er 1, R^ er CF^og R^er H, er å omsette en tiosyre med formel VIII med et akrylsyre-derivat med formelen istedenfor med forbindelsen med formel VII, og derefter fortsettes som beskrevet ovenfor. Forbindelsene med formel .XII erholdes fra 3-trifluormetylakrylsyre og en ester med formel V ved fremgangsmåten beskrevet i eksempel 14 nedenfor. A variation, which is preferred when n is 1, R₂ is CF₂ and R₂ is H, is to react a thioacid of formula VIII with an acrylic acid derivative of the formula instead of with the compound of formula VII, and then proceed as described above. The compounds of formula XII are obtained from 3-trifluoromethylacrylic acid and an ester of formula V by the method described in example 14 below.

Forbindelser med formel I hvor R erCompounds of formula I where R is

fremstilles ved direkte oksydasjon av en forbindelse med formel I hvor R er hydrogen, f.eks. med jod, for å danne den symmetriske bis-forbindelse. is produced by direct oxidation of a compound of formula I where R is hydrogen, e.g. with iodine, to form the symmetrical bis compound.

Halogenerte forbindelser med formel V som anvendes som utgangsmaterialer, kan fremstilles ved i og for seg kjente metoder, f.eks. som angitt i Biochemistry 4, 2509 (1965), Aust. J. Chem. Halogenated compounds of formula V, which are used as starting materials, can be prepared by methods known per se, e.g. as stated in Biochemistry 4, 2509 (1965), Aust. J. Chem.

20, 1493 (1967), J. Amer. Chem. Soc. 86_, 4709 (1964), J. Med. Chem. 20, 1176 (1977). 20, 1493 (1967), J. Amer. Chem. Soc. 86_, 4709 (1964), J. Med. Chem. 20, 1176 (1977).

Produktene med formel I har ett eller flere asymmetriske sentere, og det faste er det som er betegnet med en stjerne i formel I. Forbindelsene eksisterer således i stereoisomere former eller i racemiske blandinger derav. Alle disse kan fremstilles i henhold til oppfinnelsen. De ovenfor beskrevne synteser kan foretas med racematet eller en av enantiomerene som utgangsmateriale. Når det racemiske utgangsmateriale anvendes ved syntesen, kan stereoisomerene som erholdes i produktet, adskilles ved vanlige kromatografiske eller fraksjonerte krystallisasjons-metoder. Generelt er L-isomeren med hensyn til det faste asymmetriske karbonatom den foretrukne isomere form. The products of formula I have one or more asymmetric centers, and the solid is that which is denoted by an asterisk in formula I. The compounds thus exist in stereoisomeric forms or in racemic mixtures thereof. All of these can be produced according to the invention. The syntheses described above can be carried out with the racemate or one of the enantiomers as starting material. When the racemic starting material is used in the synthesis, the stereoisomers obtained in the product can be separated by usual chromatographic or fractional crystallization methods. In general, the L-isomer with respect to the fixed asymmetric carbon atom is the preferred isomeric form.

Forbindelsene som fremstilles ifølge oppfinnelsen, danner basiske salter med forskjellige uorganiske og organiske baser som også kan fremstilles ifølge oppfinnelsen. Slike salter omfatter ammoniumsalter, alkalimetallsalter så som natrium- og kaliumsalter (som foretrekkes), jordalkalimetallsalter så som kalsium- og magnesiumsalter, salter med organiske baser, f.eks. dicykloheksylaminsalter, benzatin-, N-mety1-D-glukamin-, hydrabamin-salter, salter med aminosyrer så som arginin, lysin og lignende. De ugiftige, fysiologisk godtagbare salter foretrekkes, selv om andre salter også er nyttige, f.eks. ved isolering eller rensning av produktet. The compounds produced according to the invention form basic salts with various inorganic and organic bases which can also be produced according to the invention. Such salts include ammonium salts, alkali metal salts such as sodium and potassium salts (which are preferred), alkaline earth metal salts such as calcium and magnesium salts, salts with organic bases, e.g. dicyclohexylamine salts, benzathine, N-methyl-D-glucamine, hydrabamine salts, salts with amino acids such as arginine, lysine and the like. The non-toxic, physiologically acceptable salts are preferred, although other salts are also useful, e.g. when isolating or cleaning the product.

Saltene dannes på vanlig måte ved å omsette den frie syreform av produktet med én eller flere ekvivalenter av den passende base som gir det ønskede saltion, i et oppløsningsmiddel eller medium i hvilket saltet er uoppløselig, eller i vann, hvorefter vannet fjernes ved frysetørring. Ved nøytralisering av saltet med en uoppløselig syre så som en kationebytterharpiks i hydrogenform, (f.eks. polystyrensulfonsyreharpiks så som "Dowex" 50) eller med en vandig syre og ekstraksjon med et organisk opp-løsningsmiddel, f.eks. etylacetat, diklormetan eller lignende, The salts are formed in the usual way by reacting the free acid form of the product with one or more equivalents of the appropriate base which gives the desired salt ion, in a solvent or medium in which the salt is insoluble, or in water, after which the water is removed by freeze-drying. By neutralizing the salt with an insoluble acid such as a cation exchange resin in hydrogen form, (e.g. polystyrene sulfonic acid resin such as "Dowex" 50) or with an aqueous acid and extraction with an organic solvent, e.g. ethyl acetate, dichloromethane or the like,

kan den frie syreform erholdes og eventuelt et annet salt dannes. the free acid form can be obtained and possibly another salt formed.

Ytterligere forsøksdetaljer finnes i eksemplene som representerer foretrukne utførelsesformer og også tjener som modeller for fremstilling av andre forbindelser innen gruppen. Additional experimental details are found in the examples which represent preferred embodiments and also serve as models for the preparation of other compounds within the group.

De nye forbindelser er nyttige som hypotensive midler. De hemmer omdannelsen av dekapeptidet angiotensin I til angiotensin II og er derfor nyttige til å redusere eller lindre angiotensin-forårsaket hypertensjon. Virkningen av enzymet renin på angiotensinogen, et pseudoglobulin i blodplasma, fører til dannelse av angiotensin I. Angiotensin I omdannes ved hjelp av angiotensin-omdannende enzym (ACE) til angiotensin II. The new compounds are useful as hypotensive agents. They inhibit the conversion of the decapeptide angiotensin I to angiotensin II and are therefore useful in reducing or alleviating angiotensin-induced hypertension. The action of the enzyme renin on angiotensinogen, a pseudoglobulin in blood plasma, leads to the formation of angiotensin I. Angiotensin I is converted by angiotensin-converting enzyme (ACE) to angiotensin II.

Sistnevnte er en aktiv forløper som antas å være den komponentThe latter is an active precursor that is believed to be the component

som forårsaker forskjellige former for hypertensjon i forskjellige pattedyr, f.eks. rotter og hunder. De nye forbindelser griper inn i angiotensinogen ->- (renin) -»• angiotensin I (ACE) ->-angiotensin II forløpet ved å hemme det angiotensin-omdannende enzym og redusere eller eliminere dannelsen av forløperen angiotensin II. Ved å administrere et preparat som inneholder én eller flere av forbindelsene med formel I eller fysiologisk godtagbare salter derav, lindres således angiotensin-avhengig hypertensjon i pattedyr som har denne lidelse. En enkel dose, which cause different forms of hypertension in different mammals, e.g. rats and dogs. The new compounds intervene in the angiotensinogen ->-(renin)-»• angiotensin I (ACE) ->-angiotensin II course by inhibiting the angiotensin-converting enzyme and reducing or eliminating the formation of the precursor angiotensin II. Thus, by administering a preparation containing one or more of the compounds of formula I or physiologically acceptable salts thereof, angiotensin-dependent hypertension is alleviated in mammals having this disorder. A single dose,

eller fortrinnsvis to til fire daglige doser, gitt på grunnlagor preferably two to four daily doses, given on a basis

av ca. 0,1 til 100 mg/kg pr. dag, fortrinnsvis ca. 1 til 50 mg/kg pr. dag, er passende for å redusere blodtrykket som vist ved dyremodellforsøkene beskrevet av S. L. Engel, T. R. Schaeffer, of approx. 0.1 to 100 mg/kg per day, preferably approx. 1 to 50 mg/kg per day, is appropriate for reducing blood pressure as shown by the animal model experiments described by S. L. Engel, T. R. Schaeffer,

M. H. ,Waugh og B. Rubin, Proe. Soc. Exp. Biol. Med. 143, 483 M. H. Waugh and B. Rubin, Proe. Soc. Exp. Biol. With. 143, 483

(1973).'Forbindelsen administreres fortrinnsvis oralt, men parenteral administrering kan også anvendes så som subkutan, intramuskulær, intravenøs eller intraperitoneal administrering. (1973).'The compound is preferably administered orally, but parenteral administration can also be used such as subcutaneous, intramuscular, intravenous or intraperitoneal administration.

De nye forbindelser kan anvendes for å oppnå reduksjonThe new compounds can be used to achieve reduction

av blodtrykket, ved tilberedning i preparater så som tabletter, kapsler eller eliksirer for oral administrering eller i sterile oppløsninger eller suspensjoner for parenteral administrering. Ca. 10 til 500 mg av en forbindelse eller blanding av forbindelser med formel I eller fysiologisk godtagbare salter derav blandes med et fysiologisk godtagbart bæremiddel, hjelpestoff, bindemiddel, konserveringsmiddel, stabiliseringsmiddel, smaksstoff osv. i en enhetsdoseform som passer i henhold til godtatt farmasøytisk praksis. Mengden av aktivt stoff i disse preparater er slik at en passende dosering i det angitte område oppnås. of blood pressure, by preparation in preparations such as tablets, capsules or elixirs for oral administration or in sterile solutions or suspensions for parenteral administration. About. 10 to 500 mg of a compound or mixture of compounds of formula I or physiologically acceptable salts thereof are mixed with a physiologically acceptable carrier, excipient, binder, preservative, stabilizer, flavoring agent, etc. in a unit dosage form suitable according to accepted pharmaceutical practice. The amount of active substance in these preparations is such that a suitable dosage in the specified range is achieved.

Illustrerende eksempler på de hjelpestoffer som kan innarbeides i tabletter, kapsler og lignende, er de følgende: et bindemiddel så som tragakantgummi, akasiegummi, maisstivelse eller gelatin; et hjelpestoff så som dikalsiumfos fat eller mikrokrystallinsk cellulose, et sprengmiddel så som maisstivelse, potetstivelse, alginsyre og lignende, et smøremiddel så som magnesiumstearat, et søtningsmiddel så som sukrose, laktose eller sakkarin; et smaksmiddel så som peppermynte, vintergrønnolje eller kirsebær. Når enhetsdoseformen er en kapsel, kan den i tillegg til materialer av ovennevnte type, inneholde et flytende bæremiddel så som en fet olje. Forskjellige andre materialer kan være til stede som belegg eller for på annen måte å modifisere den fysikalske form av enhetsdosen. F.eks. kan tabletter belegges med skjellakk, sukker eller begge. En sirup eller eliksir kan inneholde den aktive forbindelse, sukrose som søtningsmiddel, metyl- og propy1-parabener som konserveringsmiddel, et farvestoff og et smaksstoff så som kirsebær- eller appelsinsmak. Illustrative examples of the excipients that can be incorporated into tablets, capsules and the like are the following: a binder such as tragacanth gum, acacia gum, corn starch or gelatin; an auxiliary such as dicalcium phosphate or microcrystalline cellulose, a disintegrant such as corn starch, potato starch, alginic acid and the like, a lubricant such as magnesium stearate, a sweetener such as sucrose, lactose or saccharin; a flavoring such as peppermint, wintergreen oil or cherry. When the unit dosage form is a capsule, it may, in addition to materials of the above type, contain a liquid carrier such as a fatty oil. Various other materials may be present as coatings or to otherwise modify the physical form of the unit dose. E.g. tablets can be coated with shellac, sugar or both. A syrup or elixir may contain the active compound, sucrose as a sweetener, methyl and propyl parabens as a preservative, a coloring agent and a flavoring agent such as cherry or orange flavor.

Sterile preparater for injeksjon kan fremstilles i henhold til vanlig farmasøytisk praksis ved å oppløse eller suspendere det aktive stoff i et bæremiddel så som vann for injeksjon, en naturlig forekommende vegetabilsk olje så som sesamolje, kokosolje, jordnøttolje, bomullsfrøolje osv. Sterile preparations for injection may be prepared according to ordinary pharmaceutical practice by dissolving or suspending the active substance in a carrier such as water for injection, a naturally occurring vegetable oil such as sesame oil, coconut oil, peanut oil, cottonseed oil, etc.

De følgende eksempler skal tjene til å illustrere oppfinnelsen ytterligere og utgjør særlig foretrukne utførelses-former. Alle temperaturer er i °C. The following examples shall serve to further illustrate the invention and constitute particularly preferred embodiments. All temperatures are in °C.

Eksempel 1Example 1

3- acetyltio- 2- trifluormetylpropansyre3- acetylthio- 2- trifluoromethylpropanoic acid

En blanding av tioleddiksyre (50 g) og 2-(trifluormetyl)-akrylsyre [M.W. Buxton et al, J. Chem. Soc, 366 (1954)] (66 g) oppvarmes på dampbad i 1 time og lagres derefter ved romtemperatur i 18 timer. Reaksjonsblandingen destilleres i vakuum for å gi 3-acetyltio-2-trifluormetylpropansyre. A mixture of thiolacetic acid (50 g) and 2-(trifluoromethyl)acrylic acid [M.W. Buxton et al., J. Chem. Soc, 366 (1954)] (66 g) is heated on a steam bath for 1 hour and then stored at room temperature for 18 hours. The reaction mixture is distilled in vacuo to give 3-acetylthio-2-trifluoromethylpropanoic acid.

Eksempel 2 Example 2

1-( 3- acetyl- tio- 2- trifluormetylpropanoyl)- L- prolin- tert- butylester 1-( 3- acetyl- thio- 2- trifluoromethylpropanoyl)- L- proline- tert-butyl ester

L-prolin-tert-butylester (5,1 g) oppløses i diklormetan (40 mg), og oppløsningen omrøres og avkjøles i et isbad. Dicykloheksylkarbodiimid (6,9 g) oppløst i diklormetan (15 ml) tilsettes, umiddelbart fulgt av en oppløsning av 3-acetyltio-2-tri fluormetylpropansyre (6,5 g) i diklormetan (5 ml). Efter 15 minutters omrøring i isbad og 16 timer ved romtemperatur L-proline tert-butyl ester (5.1 g) is dissolved in dichloromethane (40 mg), and the solution is stirred and cooled in an ice bath. Dicyclohexylcarbodiimide (6.9 g) dissolved in dichloromethane (15 ml) is added, immediately followed by a solution of 3-acetylthio-2-trifluoromethylpropanoic acid (6.5 g) in dichloromethane (5 ml). After 15 minutes of stirring in an ice bath and 16 hours at room temperature

frafiltreres det dannede bunnfall, og filtratet konsentreres til tørrhet i vakuum. Residuet oppløses i etylacetat og vaskes nøytralt. Den organiske fase tørres over magnesiumsulfat og konsentreres til tørrhet i vakuum for å gi 1-(3-acetyltio-2-trifluormetylpropanoyl)-L-prolin-tert-butylester. the formed precipitate is filtered off, and the filtrate is concentrated to dryness in vacuo. The residue is dissolved in ethyl acetate and washed neutrally. The organic phase is dried over magnesium sulfate and concentrated to dryness in vacuo to give 1-(3-acetylthio-2-trifluoromethylpropanoyl)-L-proline tert-butyl ester.

Eksempel 3Example 3

1-( 3- acetyltio- 2- trifluormetylpropanoyl)- L- prolin 1-(3-acetyltio-2-trifluormetylpropanoyl)-L-prolin-tert-butylester (8 g) oppløses i en blanding av anisol (55 ml) og trifluoreddiksyre (110 ml). Efter 1 times lagring ved romtemperatur fjernes oppløsningsmidlet i vakuum, og residuet ut-felles flere ganger fra eter-heksan for å gi 1-(3-acetyltio-2-trifluormety1-propanoyl)-L-prolin. 1-(3-acetylthio-2-trifluoromethylpropanoyl)-L-proline 1-(3-acetylthio-2-trifluoromethylpropanoyl)-L-proline tert-butyl ester (8 g) is dissolved in a mixture of anisole (55 ml) and trifluoroacetic acid (110ml). After 1 hour of storage at room temperature, the solvent is removed in vacuo, and the residue is precipitated several times from ether-hexane to give 1-(3-acetylthio-2-trifluoromethyl-propanoyl)-L-proline.

Eksempel 4Example 4

1-( 3- merkapto- 2- trifluormetylpropanoyl)- L- prolin 1-(3-mercapto-2-trifluoromethylpropanoyl)-L-proline

1-(3-acetyltio-2-trifluormetylpropanoyl)-L-prolin (4 g) oppløses i en blanding av vann (8 ml) og konsentrert ammoniakk (8 ml) under et teppe av nitrogen. Efter 25 minutters omrøring 1-(3-acetylthio-2-trifluoromethylpropanoyl)-L-proline (4 g) is dissolved in a mixture of water (8 ml) and concentrated ammonia (8 ml) under a blanket of nitrogen. After 25 minutes of stirring

ved romtemperatur avkjøles reaksjonsblandingen, surgjøres og ekstraheres med etylacetat. Det organiske lag konsentreres til tørrhet i vakuum for å gi 1-(3-merkapto-2-trifluormetyl-pxopanoyl)-L-prolin. at room temperature, the reaction mixture is cooled, acidified and extracted with ethyl acetate. The organic layer is concentrated to dryness in vacuo to give 1-(3-mercapto-2-trifluoromethyl-pxopanoyl)-L-proline.

Eksempel 5Example 5

2- brom- 3, 3, 3- trifluorpropansyre2- bromo- 3, 3, 3- trifluoropropanoic acid

3 , 3 , 3-trif luoralanin (.88 g) oppløses i en blanding av kaliumbromid (250 g) og 2,5N svovelsyre (1.240 ml). Oppløsningen avkjøles til 0° med et is-salt-bad og natriumnitritt (65,5 g) tilsettes i små porsjoner over en periode på 1 time under kraftig omrøring. Reaksjonsblandingen omrøres i kjølebadet i ytterligere 1 time og ekstraheres derefter med eter. Det organiske lag vaskes med vann, tørres over magnesiumsulfat og konsentreres til tørrhet i vakuum for å gi 2-brom-3,3,3-trifluorpropansyre. 3,3,3-trifluoroalanine (.88 g) is dissolved in a mixture of potassium bromide (250 g) and 2.5N sulfuric acid (1,240 ml). The solution is cooled to 0° with an ice-salt bath and sodium nitrite (65.5 g) is added in small portions over a period of 1 hour with vigorous stirring. The reaction mixture is stirred in the cooling bath for a further 1 hour and then extracted with ether. The organic layer is washed with water, dried over magnesium sulfate and concentrated to dryness in vacuo to give 2-bromo-3,3,3-trifluoropropanoic acid.

Eksempel 6Example 6

2- brom- 3, 3, 3- trifluorpropansyreklorid.2- bromo- 3, 3, 3- trifluoropropanoic acid chloride.

En oppløsning av 2-brom-3,3,3-trifluorpropansyre (5 g)A solution of 2-bromo-3,3,3-trifluoropropanoic acid (5 g)

i tionylklorid (5 ml) tilbakeløpsbehandles i dampbad i 2 timer. Overskudd av tionylklorid fjernes i vakuum, og residuet destilleres under redusert trykk for å gi 2-brom-3,3,3-trifluorpropansyreklorid . in thionyl chloride (5 ml) is refluxed in a steam bath for 2 hours. Excess thionyl chloride is removed in vacuo, and the residue is distilled under reduced pressure to give 2-bromo-3,3,3-trifluoropropanoic acid chloride.

Eksempel 7Example 7

1-( 2- acetyltio- 3, 3, 3- trifluorpropanoy1)- L- prolin1-( 2- acetylthio- 3, 3, 3- trifluoropropanoy1)- L- proline

Til en oppløsning av L-prolin (5,75 g) i IN natriumhydroksyd (50 ml), avkjølt i et is-vann-bad, settes 2-brom-3,3,3-trifluorpropansyreklorid (12 g), og blandingen omrøres kraftig ved romtemperatur i 3 timer< En oppløsning av tioleddiksyre (4 ml) og kaliumkarbonat (4,8 g) i vann (50 ml) tilsettes, og blandingen omr.øres ved romtemperatur i 16 timer. Efter ekstraksjon med etylacetat surgjøres det vandige lag med konsentrert saltsyre og ekstraheres igjen med etylacetat. Denne siste organiske fase tørres over magnesiumsulfat og konsentreres til tørrhet i vakuum. Residuet kromatograferes på en silikagelkolonne med en blanding To a solution of L-proline (5.75 g) in 1N sodium hydroxide (50 ml), cooled in an ice-water bath, is added 2-bromo-3,3,3-trifluoropropanoic acid chloride (12 g) and the mixture is stirred vigorously at room temperature for 3 hours< A solution of thiolacetic acid (4 ml) and potassium carbonate (4.8 g) in water (50 ml) is added, and the mixture is stirred at room temperature for 16 hours. After extraction with ethyl acetate, the aqueous layer is acidified with concentrated hydrochloric acid and extracted again with ethyl acetate. This last organic phase is dried over magnesium sulfate and concentrated to dryness in vacuo. The residue is chromatographed on a silica gel column with a mixture

av benzen-eddiksyre (7:2) for å gi 1-(2-acetyltio-3,3,3-trifluor-propanoyl)-L-prolin. of benzene-acetic acid (7:2) to give 1-(2-acetylthio-3,3,3-trifluoro-propanoyl)-L-proline.

Eksempel 8Example 8

1- ( 2- merkapto- 3, 3, 3- trifluorpropanoyl)- L- prolin 1-( 2- mercapto-3, 3, 3- trifluoropropanoyl)- L- proline

1-(2-acetyltio-3,3,3-trifluorpropanoyl)-L-prolin (4 g) oppløses i en blanding av vann (8 ml) og konsentrert ammoniakk (8 ml) under et teppe av nitrogen. Efter 30 minutter ved romtemperatur surgjøres reaksjonsblandingen og ekstraheres med etylacetat. Den organiske fase tørres over magnesiumsulfat og konsentreres til tørrhet i vakuum for å gi 1-(2-merkapto-3,3,3-trifluorpropanoyl)-L-prolin. 1-(2-acetylthio-3,3,3-trifluoropropanoyl)-L-proline (4 g) is dissolved in a mixture of water (8 ml) and concentrated ammonia (8 ml) under a blanket of nitrogen. After 30 minutes at room temperature, the reaction mixture is acidified and extracted with ethyl acetate. The organic phase is dried over magnesium sulfate and concentrated to dryness in vacuo to give 1-(2-mercapto-3,3,3-trifluoropropanoyl)-L-proline.

Eksempel 9 Example 9

1, 1'-[ ditiobis-( 2- trifluormetyl- 3- propanoyl)]- bis- L- prolin 1, 1'-[dithiobis-(2-trifluoromethyl-3-propanoyl)]-bis-L-proline

1-(3-merkapto-2-trifluormetylpropanoyl)-L-prolin (1 g) oppløses i vann regulert til pH 7 med N natriumhydroksyd. En etanolisk oppløsning av jod tilsettes dråpevis mens pH-verdien holdes mellom 6 og 7 ved forsiktig tilsetning av N natriumhydroksyd. Når man får en varig gulfarve, stanses tilsetningen av jod, 1-(3-mercapto-2-trifluoromethylpropanoyl)-L-proline (1 g) is dissolved in water adjusted to pH 7 with N sodium hydroxide. An ethanolic solution of iodine is added dropwise while the pH value is kept between 6 and 7 by careful addition of N sodium hydroxide. When a permanent yellow color is obtained, the addition of iodine is stopped,

og farven fjernes med natriumtiosulfat. Reaksjonsblandingen sur-gjøres og ekstraheres med etylacetat. Det organiske lag tørres over magnesiumsulfat og konsentreres til tørrhet for å gi 1,1'-[ditiobis-(2-tri fluormetyl-3-propanoyl)]-bis-L-prolin. and the color is removed with sodium thiosulphate. The reaction mixture is acidified and extracted with ethyl acetate. The organic layer is dried over magnesium sulfate and concentrated to dryness to give 1,1'-[dithiobis-(2-trifluoromethyl-3-propanoyl)]-bis-L-proline.

Eksempel 10 Example 10

1-( 3- acetyltio- 2- trifluormetylpropanoyl)- L- prolin- natriumsalt1-( 3- acetylthio- 2- trifluoromethylpropanoyl)- L- proline sodium salt

En suspensjon av 1-(3-acetyltio-2-trifluormetylpropanoyl ) -L-prolin (1 g) i vann (10 ml) reguleres til pH 8 A suspension of 1-(3-acetylthio-2-trifluoromethylpropanoyl)-L-proline (1 g) in water (10 ml) is adjusted to pH 8

ved tilsetning av N natriumhydroksyd.. Den resulterende opp-løsning frysetørres for å gi 1-(3-acetyltio-2-trifluormetylpropanoyl) -L-prolin-natriumsalt. by addition of N sodium hydroxide. The resulting solution is freeze-dried to give 1-(3-acetylthio-2-trifluoromethylpropanoyl)-L-proline sodium salt.

Eksempel 11 Example 11

1-( 3- acetyltio- 2- trifluormetylpropanoyl)- 4, 4- difluor- L- prolin1-( 3- acetylthio- 2- trifluoromethylpropanoyl)- 4, 4- difluoro- L- proline

Til en oppløsning av 4,4-difluor-2-prolin (7,5 g) iTo a solution of 4,4-difluoro-2-proline (7.5 g) i

N natriumhydroksyd (50 ml) avkjølt i et is-vann-bad, settes 3-acetyltio-2-trifluormetylpropansyreklorid (fremstilt fra 3-acetyltio-2-trifluormetylpropansyre og tionylklorid ved fremgangsmåten ifølge eksempel 6) (12 g), og blandingen omrøres kraftig ved romtemperatur i 2 timer. Efter surgjøring med konsentrert saltsyre ekstraheres den vandige blanding med etylacetat. Den organiske fase tørres over magnesiumsulfat og. konsentreres til tørrhet for å gi 1- (3-acetyltio-2-trifluormetylpropanoyl) -4,4-difluor-L-prolin. N sodium hydroxide (50 ml) cooled in an ice-water bath, 3-acetylthio-2-trifluoromethylpropanoic acid chloride (prepared from 3-acetylthio-2-trifluoromethylpropanoic acid and thionyl chloride by the method according to example 6) (12 g) is added, and the mixture is stirred vigorously at room temperature for 2 hours. After acidification with concentrated hydrochloric acid, the aqueous mixture is extracted with ethyl acetate. The organic phase is dried over magnesium sulfate and. concentrated to dryness to give 1-(3-acetylthio-2-trifluoromethylpropanoyl)-4,4-difluoro-L-proline.

Eksempel 12 Example 12

1- ( 3- merkapto- 2- trifluormetylpropanoyl)- 4, 4- difluor- L- prolin1-( 3- mercapto- 2- trifluoromethylpropanoyl)- 4, 4- difluoro- L- proline

Ved å anvende 1-(3-acetyltio-2-trifluormetylpropanoyl)-4,4-difluor-L-prolin istedenfor 1-(3-acetyltio-2-trifluormetylpropanoyl) -L-prolin ved fremgangsmåten ifølge eksempel 4, By using 1-(3-acetylthio-2-trifluoromethylpropanoyl)-4,4-difluoro-L-proline instead of 1-(3-acetylthio-2-trifluoromethylpropanoyl)-L-proline in the method according to example 4,

får man 1-(3-merkapto-2-trifluormetylpropanoyl)-4,4-difluor-L-prolin. 1-(3-mercapto-2-trifluoromethylpropanoyl)-4,4-difluoro-L-proline is obtained.

Eksempel 13 Example 13

1, 1'-[ ditiobis-( 2- trifluormety1- 3- propanoyl)]- bis- 4, 4- di fluor-L- prolin 1,1'-[dithiobis-(2-trifluoromethyl-3-propanoyl)]-bis-4,4-difluoro-L-proline

Ved å anvende 1-(3-merkapto-2-trifluormetylpropanoyl)-4,4-difluor-L-prolin istedenfor 1-(3-merkapto-2-trifluormety1-propanoyl)-L-prolin ved fremgangsmåten ifølge eksempel 9, får man 1,1-[ditiobis-(2-trifluormetyl-3-propanoyl)]-bis-4,4^difluor-L-prolin. By using 1-(3-mercapto-2-trifluoromethylpropanoyl)-4,4-difluoro-L-proline instead of 1-(3-mercapto-2-trifluoromethyl-propanoyl)-L-proline in the method according to example 9, one obtains 1,1-[dithiobis-(2-trifluoromethyl-3-propanoyl)]-bis-4,4^difluoro-L-proline.

Eksempel 14Example 14

1-( 4, 4, 4- trifluor- 2- butenpyl)- L- prolin1-(4,4,4-trifluoro-2-butenyl)-L-proline

Borsyreanhydrid (7,0 g, 0,1 mol) (fremstilt ved å smelte borsyre i en platinadigel og knuse den under nitrogen) blandes med etyl-3-hydroksy-4,4,4-trifluorbutanoat (32,2 g, 0,173 mol) i en 50 ml kolbe utstyrt med en Dean-Stark-felle, Boric anhydride (7.0 g, 0.1 mol) (prepared by melting boric acid in a platinum crucible and crushing it under nitrogen) is mixed with ethyl 3-hydroxy-4,4,4-trifluorobutanoate (32.2 g, 0.173 mol ) in a 50 mL flask fitted with a Dean-Stark trap,

og blandingen oppvarmes ved 180° med et saltbad inntil alt anhydridet er oppløst (6 timer). Temperaturen heves til 350° and the mixture is heated at 180° with a salt bath until all the anhydride is dissolved (6 hours). The temperature is raised to 350°

og i løpet av denne tid oppsamles 23 ml destillat i fellen. Destillatet føres tilbake til reaksjonskolben, og oppvarmnings-trinnet gjentas. Denne prosess gjentas 4 ganger for å sikre fullstendig dehydratisering av hydroksyesteren. Destillatet opp-løses i petroleter, tørres over fos forpentoksyd og destilleres for å gi 10 g 4,4,4-trifluor-2-butensyre-etylester (k.p. 115-120°) og 650 mg 4,4,4-trifluor-2-butensyre (k.p. 150°, 53-55° omkrystallisering fra pentan). and during this time 23 ml of distillate is collected in the trap. The distillate is returned to the reaction flask, and the heating step is repeated. This process is repeated 4 times to ensure complete dehydration of the hydroxyester. The distillate is dissolved in petroleum ether, dried over phosphorus pentoxide and distilled to give 10 g of 4,4,4-trifluoro-2-butenoic acid ethyl ester (b.p. 115-120°) and 650 mg of 4,4,4-trifluoro-2 -butenoic acid (b.p. 150°, 53-55° recrystallization from pentane).

Esteren blandes med 10%ig vandig natriumhydroksyd (24 ml) og omrøres ved 25° i 6 timer. Blandingen fortynnes med vann og ekstraheres med metylenklorid for å fjerne uendret materiale. The ester is mixed with 10% aqueous sodium hydroxide (24 ml) and stirred at 25° for 6 hours. The mixture is diluted with water and extracted with methylene chloride to remove unchanged material.

Det vandige lag reguleres til pH 3 med konsentrert saltsyre,The aqueous layer is adjusted to pH 3 with concentrated hydrochloric acid,

og denne blanding ekstraheres med metylenklorid (3 x 50 ml).and this mixture is extracted with methylene chloride (3 x 50 ml).

De organiske lag samles,, tørres over natriumsulfat, konsentreres, og residuet destilleres for å gi krystallinsk 4 ,4 ,4-trif luor-^ 2-butensyre (k.p. 145-153°). Efter omkrystallisering fra pentan smelter syren ved 54-55°, utbytte 4,6 g. The organic layers are collected, dried over sodium sulfate, concentrated, and the residue distilled to give crystalline 4,4,4-trifluoro-^2-butenoic acid (b.p. 145-153°). After recrystallization from pentane, the acid melts at 54-55°, yield 4.6 g.

En blanding av 4,4,4-trifluor-2-butensyre (4,91 g,A mixture of 4,4,4-trifluoro-2-butenoic acid (4.91 g,

35 mmol), hydroksybenzotriazol (4,73 g, 35 mmol), L-prolin-t-buty1-ester (6,00 g, 35 mmol) og dicykloheksylkarbodiimid (7,22 g, 35 mmol) i metylenklorid (200 ml) omrøres under nitrogen natten over ved romtemperatur. Blandingen filtreres, og filtratet vaskes med 5%ig natriumbisulfat (2 x 50 ml) og mettet natriumbikarbonat (2 x 50 ml), tørres over natriumsulfat og konsentreres for å gi en olje. Denne oppløses i eter, og oppløsningen avkjøles og filtreres fri for bunnfall. Filtratet konsentreres for å gi et fast stoff (sm.p. 95-100°, 8,7 g) som viser en enkel flekk ved TLC (silikagel EM 50/50, Et0Ac/CH2Cl2, Rf = 0,85). 35 mmol), hydroxybenzotriazole (4.73 g, 35 mmol), L-proline-t-butyl ester (6.00 g, 35 mmol) and dicyclohexylcarbodiimide (7.22 g, 35 mmol) in methylene chloride (200 mL) stirred under nitrogen overnight at room temperature. The mixture is filtered, and the filtrate is washed with 5% sodium bisulfate (2 x 50 ml) and saturated sodium bicarbonate (2 x 50 ml), dried over sodium sulfate and concentrated to give an oil. This is dissolved in ether, and the solution is cooled and filtered free of precipitate. The filtrate is concentrated to give a solid (m.p. 95-100°, 8.7 g) which shows a single spot by TLC (silica gel EM 50/50, Et0Ac/CH2Cl2, Rf = 0.85).

En blanding av den ovenfor erholdte 1-(4,4,4-trifluor-2-butenoyl)-L-prolin-t-butylester (4,0 g, 13,6 mmol) blandes med trifluoreddiksyre (60 ml) og anisol (13 ml) og omrøres under nitrogen i 1 time. Oppløsningsmidlene fjernes under vakuum, og residuet, oppløst i eter (10 ml) helles i pentan (500 ml). A mixture of the 1-(4,4,4-trifluoro-2-butenoyl)-L-proline-t-butyl ester obtained above (4.0 g, 13.6 mmol) is mixed with trifluoroacetic acid (60 ml) and anisole ( 13 ml) and stirred under nitrogen for 1 hour. The solvents are removed under vacuum and the residue, dissolved in ether (10 ml) is poured into pentane (500 ml).

Denne utfelningsteknikk gjentas, og residuet får stå ved 0° iThis precipitation technique is repeated, and the residue is allowed to stand at 0° i

72 timer, i løpet av hvilken tid krystallisering finner sted. 72 hours, during which time crystallization takes place.

1-(4,4,4-trifluor-2-butenoyl)-L-prolin omkrystalliseres fra etylacetat-heksan; utbytte 2,48 g, sm.p. 119-120°. 1-(4,4,4-trifluoro-2-butenoyl)-L-proline is recrystallized from ethyl acetate-hexane; yield 2.48 g, m.p. 119-120°.

Eksempel 15Example 15

1- ( 3- merkapto- 4, 4, 4- trifluorbutanoy1)- L- prolin1-( 3- mercapto-4, 4, 4- trifluorobutanoy1)- L- proline

Tioleddiksyre (1,5 ml) blandes med 1-(4,4,4-trifluor-2- butenoyl)-L-prolin (720 mg, 3 mmol) under argon, og blandingen omrøres ved romtemperatur natten over. Overskudd av tioleddiksyre, fjernes under vakuum, og gjenværende 1-(3-acetyltio-4,4,4-trifluorbutanoyl)-L-prolin blandes méd vandig ammoniakk Thiolacetic acid (1.5 mL) is mixed with 1-(4,4,4-trifluoro-2-butenoyl)-L-proline (720 mg, 3 mmol) under argon, and the mixture is stirred at room temperature overnight. Excess thiolacetic acid is removed under vacuum, and remaining 1-(3-acetylthio-4,4,4-trifluorobutanoyl)-L-proline is mixed with aqueous ammonia

(15 ml konsentrert NH^+ 15 ml vann) og omrøres i 2 timer ved romtemperatur. Blandingen fortynnes derefter med is og surgjøres med konsentrert saltsyre. Syreblandingen ekstraheres med metylenklorid (3 x 50 ml), ekstraktene tørres over natriumsulfat og konsentreres for å gi en olje. Denne renses ved oppløsning (15 ml concentrated NH^ + 15 ml water) and stirred for 2 hours at room temperature. The mixture is then diluted with ice and acidified with concentrated hydrochloric acid. The acid mixture is extracted with methylene chloride (3 x 50 ml), the extracts are dried over sodium sulfate and concentrated to give an oil. This is cleaned by dissolution

i vann (dobbelt-destillert), oppløsningen behandles med kull og in water (double-distilled), the solution is treated with charcoal and

filtreres gjennom et "Millipore" filter (0,4 pm fulgt av 0,08 ym). Lyofilisering av denne oppløsning gir 700 mg 1-(3-merkapto-4,4,4-trifluorbutanoy1)-L-prolin som et far<y>eløst glass. filtered through a "Millipore" filter (0.4 pm followed by 0.08 ym). Lyophilization of this solution gives 700 mg of 1-(3-mercapto-4,4,4-trifluorobutanoyl)-L-proline as a harmless glass.

Rf (benzen:eddiksyre 7:1) 0,24.Rf (benzene:acetic acid 7:1) 0.24.

Eksempel 16Example 16

3- acetyltio- 4, 4, 4- trifluorbutansyreklorid3- acetylthio- 4, 4, 4- trifluorobutanoic acid chloride

Ved å anvende 4,4,4-trifluor-2-butensyre istedenfor 2-trifluormety1-akrylsyre ved fremgangsmåten ifølge eksempel 1 får man 3-acetyltio-4,4,4-trifluorbutansyre, og dette kloreres derefter med tionylklorid som i eksempel 6 for å gi 3-acetyltio-4,4,4-trifluorbutansyreklorid. By using 4,4,4-trifluoro-2-butenoic acid instead of 2-trifluoromethyl-acrylic acid in the method according to example 1, 3-acetylthio-4,4,4-trifluorobutanoic acid is obtained, and this is then chlorinated with thionyl chloride as in example 6 for to give 3-acetylthio-4,4,4-trifluorobutanoic acid chloride.

Eksempel 17 Example 17

1-( 3- merkapto- 4, 4, 4- trifluorbutanoyl)- 4, 4- difluor- L- prolin1-(3-mercapto-4,4,4-trifluorobutanoyl)-4,4-difluoro-L-proline

Ved å anvende 1-(3-acetyltio-4,4,4-trifluorbutansyreklorid istedenfor 3-acetyltio-2-trifluormetylpropansyreklorid ved fremgangsmåten ifølge eksempel 11 og derefter underkaste produktet fremgangsmåten ifølge eksempel 4, får man 1-(3-merkapto-4,4,4-trifluorbutanoyl)-4,4-difluor-L-prolin. By using 1-(3-acetylthio-4,4,4-trifluorobutanoic acid chloride instead of 3-acetylthio-2-trifluoromethylpropanoic acid chloride in the method according to example 11 and then subjecting the product to the method according to example 4, one obtains 1-(3-mercapto-4, 4,4-trifluorobutanoyl)-4,4-difluoro-L-proline.

Eksempel 18 Example 18

1, 1'-[ ditiobis-( 4, 4, 4- trifluor- 3- butanoyl)]- bis- L- prolin1,1'-[dithiobis-(4,4,4-trifluoro-3-butanoyl)]-bis-L-proline

Ved å anvende 1-(3-merkapto-4,4,4-trifluorbutanoyl)-L-prolin istedenfor 1-(3-merkapto-2-trifluormetylpropanoyl)-L-prolin ved fremgangsmåten ifølge eksempel 11, får man 1,1'-[ditiobis-(4,4,4-trifluor-3-butanoyl)]-bis-L-prolin. By using 1-(3-mercapto-4,4,4-trifluorobutanoyl)-L-proline instead of 1-(3-mercapto-2-trifluoromethylpropanoyl)-L-proline in the method according to example 11, one obtains 1,1' -[dithiobis-(4,4,4-trifluoro-3-butanoyl)]-bis-L-proline.

Eksempel 19Example 19

cis- 4- fluor- L- prolin- hydrobromidcis- 4-fluoro-L-proline hydrobromide

a) N- karbobenzyloksy- 4- hydroksy- L- prolin- metylester N-karbobenzyloksy-4-hydroksy-L-prolin [12,4 g (0,047 mol)] a) N-carbobenzyloxy-4-hydroxy-L-proline methyl ester N-carbobenzyloxy-4-hydroxy-L-proline [12.4 g (0.047 mol)]

forestres med diazometan i dioksan-eter som beskrevet i JACS, 79, 191 (1957). For å unngå at dioksanet fryser startes tilsetningen av diazometanoppløsningen ved 10° og fullføres ved 0-2°. Utbyttet av nesten farveløs, viskøs olje er 14,6 g (100%). is esterified with diazomethane in dioxane ether as described in JACS, 79, 191 (1957). To avoid the dioxane freezing, the addition of the diazomethane solution is started at 10° and completed at 0-2°. The yield of almost colorless, viscous oil is 14.6 g (100%).

b) N- karbobenzyloksy- 4- tosyloksy- L- prolin- metylesterb) N-carbobenzyloxy-4-tosyloxy-L-proline methyl ester

En omrørt oppløsning av 14,5 g (0,052 mol) N-karbo-benzy loksy-4-hydroksy-L-prolin-mety lester i 30 ml pyridin behandles dråpevis ved -5° til -8° med en oppløsning av 11 g A stirred solution of 14.5 g (0.052 mol) of N-carbo-benzyloxy-4-hydroxy-L-proline-methyl ester in 30 ml of pyridine is treated dropwise at -5° to -8° with a solution of 11 g

(0,058 mol) tosylklorid i 15 ml pyridin. Den blekgule opp-løsning lagres avkjølt i 3 dager og settes derefter under om-røring til 300 ml iskold 2N saltsyre. Den utfelte gummi ekstraheres med 200 ml kloroform. Den vandige fase ekstraheres, med ytterligere kloroform (3 x 100 ml). De organiske lag samles, tørres (MgSO^), og oppløsningsmidlet avdampes for å gi en blekgul, viskøs olje. Oljen oppløses i 100 ml metanol og fortynnes til 400 ml med vann for å utfelle produktet som en olje som gradvis krystalliserer ved kimpodning, gnidning og avkjøling: utbytte 17,4 g (77%), sm.p. 62-65°. Efter krystallisering fra 85 ml isopropanol veier den farveløse, faste N-karbobenzyloksy-4-tosyloksy-L-prolin-metylester 15,9 g (70%); sm.p. 67-69°, [a]^ -30° (c = 1, metanol). (0.058 mole) of tosyl chloride in 15 ml of pyridine. The pale yellow solution is stored chilled for 3 days and is then added, with stirring, to 300 ml of ice-cold 2N hydrochloric acid. The precipitated gum is extracted with 200 ml of chloroform. The aqueous phase is extracted with additional chloroform (3 x 100 ml). The organic layers are combined, dried (MgSO 4 ), and the solvent evaporated to give a pale yellow viscous oil. The oil is dissolved in 100 ml of methanol and diluted to 400 ml with water to precipitate the product as an oil which gradually crystallizes on seeding, rubbing and cooling: yield 17.4 g (77%), m.p. 62-65°. After crystallization from 85 ml of isopropanol, the colorless solid N-carbobenzyloxy-4-tosyloxy-L-proline methyl ester weighs 15.9 g (70%); sm.p. 67-69°, [α]^ -30° (c = 1, methanol).

c) cis- N- karbobenzyloksy- 4- fluor- L- prolin- metylesterc) cis-N-carbobenzyloxy-4-fluoro-L-proline-methyl ester

En omrørt suspensjon av 19,1 g (0,044 mol) N-karbo-benzy loksy-4-tosyloksy-L-prolin-mety lester i 100 ml redestillert dietylénglykol behandles ved 42° (under argon) med 19, 1 g (0,33 mol) vannfritt kaliumfluorid, og den resulterende opp-løsning oppvarmes ved 81-84° i 20 timer. Efter avkjøling opparbeides den lysegule oppløsning for å gi 18,6 g (100%) cis-N-karbobenzyloksy-4-fluor-L-prolin-metylester som en lysegul- olje. A stirred suspension of 19.1 g (0.044 mol) of N-carbo-benzyloxy-4-tosyloxy-L-proline-methyl ester in 100 ml of redistilled diethylene glycol is treated at 42° (under argon) with 19.1 g (0. 33 moles) of anhydrous potassium fluoride, and the resulting solution is heated at 81-84° for 20 hours. After cooling, the pale yellow solution is worked up to give 18.6 g (100%) of cis-N-carbobenzyloxy-4-fluoro-L-proline methyl ester as a pale yellow oil.

d) cis- N- karbobenzyloksy- 4- fluor- L- prolin Cis-N-karbobenzyloksy-4-fluor-L-prolin-metylester d) cis-N-carbobenzyloxy-4-fluoro-L-proline Cis-N-carbobenzyloxy-4-fluoro-L-proline methyl ester

(18,4 g, ca. 0,044 mol) oppløses i 140 ml metanol, behandles dråpevis ved -1° til 4° med 33 ml (0,066 mol) 2N natriumhydroksyd, holdes derefter ved 0° i 1 time og ved romtemperatur natten over. Efter fjernelse av ca. halvparten av oppløsningsmidlet på en rotasjonsinndamper, fortynnes oppløsningen med 300 ml vann, (18.4 g, ca. 0.044 mol) is dissolved in 140 ml of methanol, treated dropwise at -1° to 4° with 33 ml (0.066 mol) of 2N sodium hydroxide, then kept at 0° for 1 hour and at room temperature overnight. After removing approx. half of the solvent on a rotary evaporator, dilute the solution with 300 ml of water,

vaskes med eter (vaskevæsker kastes), surgjøres under avkjøling med 12,5 ml 1:1 saltsyre til pH 2, og ekstraheres med etylacetat washed with ether (washing liquids are discarded), acidified while cooling with 12.5 ml of 1:1 hydrochloric acid to pH 2, and extracted with ethyl acetate

(4 x 150 ml). Ekstraktene samles, vaskes med 100 ml mettet natriumkloridoppløsning, tørres (MgSO^), og oppløsningsmidlet avdampes for å gi 13,8 g av en blekgul, viskøs olje. Sistnevnte oppløses i 60 ml etanol, behandles med 5,1 g cykloheksylamin i 10 ml etanol og fortynnes til 900 ml med eter. Ved kimpodning og gnidning utskilles krystallinsk cis-N-karbobenzyloksy-4-fluor-L-prolin-cykloheksylaminsalt: vekt efter avkjøling natten over 11,0 g, sm.p. 180-183° (s. 175°). Efter krystallisering fra 70 ml etanol veier det farveløse, faste stoff 7,6 g, sm.p. 185-187°, [cc]j^ -40° (c = 1, metanol) . (4 x 150 ml). The extracts are combined, washed with 100 mL saturated sodium chloride solution, dried (MgSO 4 ), and the solvent evaporated to give 13.8 g of a pale yellow viscous oil. The latter is dissolved in 60 ml of ethanol, treated with 5.1 g of cyclohexylamine in 10 ml of ethanol and diluted to 900 ml with ether. During inoculation and rubbing, crystalline cis-N-carbobenzyloxy-4-fluoro-L-proline-cyclohexylamine salt is secreted: weight after cooling overnight 11.0 g, m.p. 180-183° (p. 175°). After crystallization from 70 ml of ethanol, the colorless solid weighs 7.6 g, m.p. 185-187°, [cc]j^ -40° (c = 1, methanol).

Cykloheksylaminsaltet suspenderes i 75 ml etylacetat, omrøres og behandles med 45 ml saltsyre. Lagene adskilles, The cyclohexylamine salt is suspended in 75 ml of ethyl acetate, stirred and treated with 45 ml of hydrochloric acid. The teams are separated,

den vandige fase ekstraheres med ytterligere etylacetat (2 x 75 ml), derefter tørres de samlede organiske lag (MgSO^), the aqueous phase is extracted with further ethyl acetate (2 x 75 ml), then the combined organic layers are dried (MgSO 4 ),

og oppløsningsmidlet avdampes. Den gjenværende frie syre, cis-N-karbobenzyloksy-4-fluor-L-prolin, krystalliserer efter tørring ved 0,2 mm og 45°, utbytte 5,7 g (49%), sm.p. 116-118°. and the solvent is evaporated. The remaining free acid, cis-N-carbobenzyloxy-4-fluoro-L-proline, crystallizes after drying at 0.2 mm and 45°, yield 5.7 g (49%), m.p. 116-118°.

e) cis- 4- fluor- L- prolin- hydrobromid e) cis-4-fluoro-L-proline hydrobromide

Cis-N-karbobenzyloksy-4-fluor-L-prolin (5,5 g, 0,021 mol) Cis-N-carbobenzyloxy-4-fluoro-L-proline (5.5 g, 0.021 mol)

behandles med 28 ml hydrogenbromid i eddiksyre (30-32%), til-dekkes forsiktig og omrøres i 1 time. Eter (300 ml) settes til den gule blanding, og når det krystallinske produkt har avsatt seg, dekanteres den eteriske væske, og materialet vaskes med 300 ml frisk eter ved dekantering. Produktet oppvarmes endelig i dampbad med 70 ml metyletylketon, avkjøles i 2 timer, vaskes med kald metyletylketon og med eter og tørres i vakuum. Utbyttet av nesten farveløst, fast stoff, cis-4-fluor-L-prolin-hydrobromid er 3,8 g (86%), sm.p. 189-191° (spaltn.), [a]^<6>-19° (c = 1, metanol). treated with 28 ml of hydrogen bromide in acetic acid (30-32%), carefully covered and stirred for 1 hour. Ether (300 ml) is added to the yellow mixture, and when the crystalline product has settled, the ethereal liquid is decanted, and the material is washed with 300 ml of fresh ether by decantation. The product is finally heated in a steam bath with 70 ml of methyl ethyl ketone, cooled for 2 hours, washed with cold methyl ethyl ketone and with ether and dried in vacuum. The yield of almost colorless solid, cis-4-fluoro-L-proline hydrobromide is 3.8 g (86%), m.p. 189-191° (dec.), [α]^<6>-19° (c = 1, methanol).

Noe av det rå hydrobromidsalt omdannes til den frie syre ved å føre det gjennom en kolonne av "Dowex" 1-X8 ionebytter-harpiks. Some of the crude hydrobromide salt is converted to the free acid by passing it through a column of "Dowex" 1-X8 ion exchange resin.

Eksempel 20 Example 20

cis- 1-[ D- 3-( acetyltio)- 2- metylpropanoyl]- 4- fluor- L- prolin cis-4-fluor-L-prolin-hydrobromid (4,5 g, 0,021 mol) cis-1-[D-3-(acetylthio)-2-methylpropanoyl]-4-fluoro-L-proline cis-4-fluoro-L-proline hydrobromide (4.5 g, 0.021 mol)

og 4,2 g (0,023 mol) D-3-acetyltio-2-metylpropansyreklorid omsettes i 50 ml vann i nærvær av natriumkarbonat for å stabilisere pH-verdien ved 8,0-8,2 under acyleringen (ca. 20 minutter). Blandingen opparbeides efter ytterligere 1 time ved vasking med etylacetat (2 x 50 ml), tildekking med et lag av etylacetat, surgjøring med saltsyre til pH 2, metning med natriumklorid og derefter separering av lagene. Den vandige fase ekstraheres med ytterligere etylacetat, og de organiske lag samles, tørres og inndampes. Det faste residuum fra etylacetat-avdampningen and 4.2 g (0.023 mol) of D-3-acetylthio-2-methylpropanoic acid chloride are reacted in 50 ml of water in the presence of sodium carbonate to stabilize the pH at 8.0-8.2 during the acylation (about 20 minutes). The mixture is worked up after a further 1 hour by washing with ethyl acetate (2 x 50 ml), covering with a layer of ethyl acetate, acidifying with hydrochloric acid to pH 2, saturating with sodium chloride and then separating the layers. The aqueous phase is extracted with additional ethyl acetate, and the organic layers are collected, dried and evaporated. The solid residue from the ethyl acetate evaporation

gnies under eter, og inndampningen gjentas; vekt av farveløst produkt, 5,4 g (93%), sm.p. 146-148° (s. 133°), [a]^<6>-132° rubbed under ether, and the evaporation repeated; weight of colorless product, 5.4 g (93%), m.p. 146-148° (p. 133°), [a]^<6>-132°

(c = 1, metanol). Dicykloheksylaminsaltet fremstilles ved å sette dicykloheksylamin til cis-1-[D-3-(acetyltio)-2-metylpropanoyl-4-fluor-L-prolin i 70 ml etylacetat. 8,1 g salt, som (c = 1, methanol). The dicyclohexylamine salt is prepared by adding dicyclohexylamine to cis-1-[D-3-(acetylthio)-2-methylpropanoyl-4-fluoro-L-proline in 70 ml of ethyl acetate. 8.1 g of salt, which

utkrystalliserer, oppnås, sm.p. 202-204° (s. 187°), [a]^6 -72°crystallizes, is obtained, m.p. 202-204° (p. 187°), [a]^6 -72°

(c = 1, metanol). Krystallisering fra 90 ml isopropanol gir 7,0 g, sm.p, 205-207° (s, 190°). [a]^<6>-74°. En prøve omkrystallisert fra etanol viser ingen ytterligere forandring i sm.p. eller [a]D- (c = 1, methanol). Crystallization from 90 ml of isopropanol gives 7.0 g, m.p., 205-207° (s, 190°). [a]^<6>-74°. A sample recrystallized from ethanol shows no further change in m.p. or [a]D-

Dicykloheksylaminsaltet (16,9 g) omdannes tilbake tilThe dicyclohexylamine salt (16.9 g) is converted back to

den frie syre ved fordeling mellom 10%ig kaliumbisulfat og etylacetat (60 ml 10%ig KHSO^, 4 x 50 ml etylacetat-ekstraksjoner). De organiske lag samles og inndampes til tørrhet for å gi 4,1 g (71%) farveløs, fri syre, sm.p. 154-156° (s. 140°) [a]^<6>-142° the free acid by partitioning between 10% potassium bisulphate and ethyl acetate (60 ml 10% KHSO^, 4 x 50 ml ethyl acetate extractions). The organic layers are combined and evaporated to dryness to give 4.1 g (71%) of colorless, free acid, m.p. 154-156° (p. 140°) [a]^<6>-142°

(c = 1, metanol).(c = 1, methanol).

Eksempel 21Example 21

cis- 4- fluor- 1-( D- 3- merkapto- 2- metylpropanoyl)- L- prolin cis- 4- fluoro- 1-( D- 3- mercapto- 2- methylpropanoyl)- L- proline

cis-1-[D-3-(acetyltio)-2-metylpropanoyl]-4-fluor-L-prolin (3,9 g, 0,014 mol) hydrolyseres i 22 ml vann inneholdende 9 ml konsentrert ammoniumhydroksyd. Reaksjonsblandingen surgjøres med saltsyre og ekstraheres med etylacetat. Det organiske lag konsentreres til tørrhet for å gi 3,3 g glasslignende produkt som langsomt krystalliserer når det tørres ved 0,2 mm og 50°. Materialet utgnis med 20 ml etylacetat (med svak oppvarmning cis-1-[D-3-(acetylthio)-2-methylpropanoyl]-4-fluoro-L-proline (3.9 g, 0.014 mol) is hydrolyzed in 22 ml of water containing 9 ml of concentrated ammonium hydroxide. The reaction mixture is acidified with hydrochloric acid and extracted with ethyl acetate. The organic layer is concentrated to dryness to give 3.3 g of glassy product which slowly crystallizes when dried at 0.2 mm and 50°. The material is rubbed out with 20 ml of ethyl acetate (with gentle heating

under argon), fortynnes med 25 ml heksan, gnies og avkjøles natten over (under argon). Efter filtrering under argon, vasking med heksan og tørring i vakuum veier det farveløse faste cis-4-fluor-1-(D-3-merkapto-2-metylpropanoyl)-L-prolin 2,8 g (85%) , sm.p. 135-137° (s. 129°) [a]^<6>-116° (c = 1, metanol). under argon), diluted with 25 ml of hexane, rubbed and cooled overnight (under argon). After filtration under argon, washing with hexane and drying in vacuum, the colorless solid cis-4-fluoro-1-(D-3-mercapto-2-methylpropanoyl)-L-proline weighs 2.8 g (85%), sm. p. 135-137° (p. 129°) [α]^<6>-116° (c = 1, methanol).

Eksempel 22Example 22

1- [ 3-( acetyltio)- 2- klorpropanoyl]- L- prolin1- [ 3-( acetylthio)- 2- chloropropanoyl]- L- proline

( Isomer A)(Isomer A)

L-prolin (1,44 g) og natriumkarbonat (667 mg) oppløsesL-proline (1.44 g) and sodium carbonate (667 mg) dissolve

i 17 ml vann og omrøres i et isbad. Til dette settes natriumkarbonat (2 g) i 8,5 mg vann-, umiddelbart fulgt av 3-acetyltio-2- klorpropansyreklorid (2,5 g). Isbadet fjernes. Efter 30 minutter dannes et bunnfall som solubiliseres med tilsetning av 17 ml vann. Efter totalt 1,5 timer ekstraheres reaksjons-, blandingen to ganger med etylacetat. Det vandige lag avkjøles, surgjøres med konsentrert saltsyre, mettes med natriumklorid, ekstraheres inn i etylacetat, tørres over magnesiumsulfat og konsentreres til tørrhet i vakuum for å gi produktet som en rå olje, utbytte 3,3 g. in 17 ml of water and stirred in an ice bath. To this, sodium carbonate (2 g) is added to 8.5 mg of water, immediately followed by 3-acetylthio-2-chloropropanoic acid chloride (2.5 g). The ice bath is removed. After 30 minutes, a precipitate forms which is solubilized with the addition of 17 ml of water. After a total of 1.5 hours, the reaction mixture is extracted twice with ethyl acetate. The aqueous layer is cooled, acidified with concentrated hydrochloric acid, saturated with sodium chloride, extracted into ethyl acetate, dried over magnesium sulfate and concentrated to dryness in vacuo to give the product as a crude oil, yield 3.3 g.

Oljen påføres på en 100 g silikagelkolonne og elueres med benzen/eddiksyre 7:1 for å gi 2 g produkt som krystalliserer fra vann for å gi 450 mg 1-[ 3-(acetyltio.)-2-klorpropanoyl ] - L-prolin, sm.p. 111-113°. [alD-170° (c = 1, etanol). The oil is applied to a 100 g silica gel column and eluted with benzene/acetic acid 7:1 to give 2 g of product which crystallizes from water to give 450 mg of 1-[ 3-(acetylthio.)-2-chloropropanoyl]-L-proline, sm.p. 111-113°. [alD-170° (c = 1, ethanol).

Eksempel 2 3Example 2 3

1-[ 3-( acetyltio)- 2- klorpropanoyl]- L- prolin1-[ 3-(acetylthio)-2-chloropropanoyl]-L-proline

( Isomer B)(Isomer B)

De vandige moderluter fra eksempel 22 lyofiliseres og kromatograferes på silikagel med benzen/eddiksyre 7:1. Fraksjonene som inneholder det UV-absorberende materiale og som vises å være homogene ved TLC, oppsamles, konsentreres til tørrhet og krystalliseres fra vann, utbytte 800 mg, sm.p. 90-109° The aqueous mother liquors from example 22 are lyophilized and chromatographed on silica gel with benzene/acetic acid 7:1. The fractions containing the UV-absorbing material and shown to be homogeneous by TLC are collected, concentrated to dryness and crystallized from water, yield 800 mg, m.p. 90-109°

[ct]D 25 -4 o(c = 2,1, etanol). Moderlutene konsentreres til tørrhet ved frysetørring, og gjenværende 1-[3-(acetyltio)-2-klor-propanoyl-L-prolin (isomer B) krystalliseres fra eter-heksan, utbytte 380 mg, sm.p. 108-110°, [a]^<5>+ 17,6° (c = 1,25, etanol). [ct]D 25 -4 o(c = 2.1, ethanol). The mother liquors are concentrated to dryness by freeze-drying, and the remaining 1-[3-(acetylthio)-2-chloro-propanoyl-L-proline (isomer B) is crystallized from ether-hexane, yield 380 mg, m.p. 108-110°, [α]^<5>+ 17.6° (c = 1.25, ethanol).

Eksempel 2 4Example 2 4

1- [ 3-( acetyltio)- 2- brompropanoyl]- L- prolin1- [ 3-( acetylthio)- 2- bromopropanoyl]- L- proline

Ved å anvende 3-acetyltio-2-brompropansyreklorid istedenfor 3-acetyltio-2-klorpropansyreklorid ved fremgangsmåten ifølge eksempel 22, får man 1-[3-(acetyltio)-2-brompropanoyl]-L-prolin, sm.p. 109-110°, [a]D- 162° (c - 1,39, etanol). By using 3-acetylthio-2-bromopropanoic acid chloride instead of 3-acetylthio-2-chloropropanoic acid chloride in the method according to example 22, 1-[3-(acetylthio)-2-bromopropanoyl]-L-proline is obtained, m.p. 109-110°, [α]D- 162° (c - 1.39, ethanol).

Eksempel 25 Example 25

cis- 4- klor- l-( D- 3- merkapto- 2- metylpropanoyl- L- prolincis- 4- chloro- l-( D- 3- mercapto- 2- methylpropanoyl- L- proline

Ved å anvende cis-4-klor-L-prolin [Aust. J. Chem. 20, 1493 (1967)] istedenfor cis-4-fluor-L-prolin-hydrobromid ved fremgangsmåten ifølge eksempel 20 og derefter underkaste produktet fremgangsmåten ifølge eksempel 21, får man cis-1-[D-3-(acetyltio)-2-metylpropanoyl-4-klorprolin og cis-4-klor-l-(D-3-merkapto-2-metylpropanoyl)-L-prolin. By using cis-4-chloro-L-proline [Aust. J. Chem. 20, 1493 (1967)] instead of cis-4-fluoro-L-proline hydrobromide in the method according to example 20 and then subjecting the product to the method according to example 21, one obtains cis-1-[D-3-(acetylthio)-2- methylpropanoyl-4-chloroproline and cis-4-chloro-1-(D-3-mercapto-2-methylpropanoyl)-L-proline.

Eksempel 26 Example 26

trans- 4- brom- l-( D- 3- merkapto- 2- metylpropanoyl)- L- prolintrans- 4- bromo- l-( D- 3- mercapto- 2- methylpropanoyl)- L- proline

Ved å anvende trans-4-brom-L-prolin [Aust. J. Chem. 20, 1493 (1967)] istedenfor cis-4-fluor-L-prolin-hydrobromid ved fremgangsmåten ifølge eksempel 20, og derefter underkaste produktet fremgangsmåten ifølge eksempel 21, får man trans-1- By using trans-4-bromo-L-proline [Aust. J. Chem. 20, 1493 (1967)] instead of cis-4-fluoro-L-proline hydrobromide in the method according to Example 20, and then subjecting the product to the method according to Example 21, one obtains trans-1-

[D-3-(acetyltio)-2-metylpropanoyl]-4-brom-L-prolin og trans-4-brom-l-(D-3-merkapto-2-metylpropanoyl)-L-prolin. [D-3-(acetylthio)-2-methylpropanoyl]-4-bromo-L-proline and trans-4-bromo-1-(D-3-mercapto-2-methylpropanoyl)-L-proline.

Eksempel 2 7Example 2 7

cis- 4- jod- l-( D- 3- merkapto- 2- metylpropanoyl- L- proiincis- 4- iodo- l-( D- 3- mercapto- 2- methylpropanoyl- L- proiin

Ved å anvende cis-4-jod-L-prolin istedenfor cis-4-fluor-L-prolin-hydrobromid ved fremgangsmåten ifølge eksempel 20, og derefter underkaste produktet fremgangsmåten ifølge eksempel 21, får man cis-1-[D-3-(acetyltio)-2-metylpropanoyl-4-jod-L-prolin og cis-4-jod-1-[D-3-merkapto-2-metylpropanoyl]-L-prolin. By using cis-4-iodo-L-proline instead of cis-4-fluoro-L-proline hydrobromide in the method according to Example 20, and then subjecting the product to the method according to Example 21, one obtains cis-1-[D-3- (acetylthio)-2-methylpropanoyl-4-iodo-L-proline and cis-4-iodo-1-[D-3-mercapto-2-methylpropanoyl]-L-proline.

Eksempel 2 8 Example 2 8

cis- 4- fluor- 1-( 3- merkapto- 2- trifluormetylpropanoyl)- L- prolincis- 4- fluoro- 1-( 3- mercapto- 2- trifluoromethylpropanoyl)- L- proline

Ved å anvende 3-acetyltio-2-trif luormety lpropansyre^-klorid istedenfor 3-acetyltio-2-metyIpropansyreklorid ved . fremgangsmåten ifølge eksempel 20 og derefter underkaste produktet fremgangsmåten ifølge eksempel 21, får man cis-1-[3-(acetyltio)-2-trifluormetylpropanoyl]-4-fluor-L-prolin og cis-4-fluor-1-(3-merkapto-2-trifluormetylpropanoyl)-L-prolin. By using 3-acetylthio-2-trifluoromethylpropanoic acid chloride instead of 3-acetylthio-2-methylpropanoic acid chloride at . the method according to example 20 and then subjecting the product to the method according to example 21, one obtains cis-1-[3-(acetylthio)-2-trifluoromethylpropanoyl]-4-fluoro-L-proline and cis-4-fluoro-1-(3- mercapto-2-trifluoromethylpropanoyl)-L-proline.

Eksempel 29Example 29

cis- 3- fluor- DL- prolin- hydrobromidcis- 3- fluoro- DL- proline- hydrobromide

Ved å anvende N-karbobenzyl.oksy-3-hydroksy-DL-prolinBy using N-carbobenzyl.oxy-3-hydroxy-DL-proline

[J. Am. Chem. Soc. 8_5 , 2824 (1963)] istedenfor N-karbobenzyloksy-4-hydroksy-L-prolin ved fremgangsmåten ifølge eksempel 19, får man cis-3-fluor-DL-prolin-hydrobromid. [J. Am. Chem. Soc. 8_5 , 2824 (1963)] instead of N-carbobenzyloxy-4-hydroxy-L-proline in the method according to example 19, cis-3-fluoro-DL-proline hydrobromide is obtained.

Eksempel 30 Example 30

cis- 3- fluor- 1-( D- 3- merkapto- 2- metylpropanoy1- DL- prolincis- 3- fluoro- 1-( D- 3- mercapto- 2- methylpropanoy1- DL- proline

Ved å anvende cis-3-fluor-DL-prolin-hydrobromid istedenfor cis-4-fluor-DL-prolin ved fremgangsmåten ifølge eksempel 20 og derefter underkaste produktet fremgangsmåten ifølge eksempel 21, får man cis-1-[D-3-(acetyltio)-2-metylpropanoyl]-3-fluor-DL-prolin og cis-3-fluor-1-(D-3-merkapto-2-metylpropanoyl)-DL-prolin. By using cis-3-fluoro-DL-proline hydrobromide instead of cis-4-fluoro-DL-proline in the method according to Example 20 and then subjecting the product to the method according to Example 21, one obtains cis-1-[D-3-( acetylthio)-2-methylpropanoyl]-3-fluoro-DL-proline and cis-3-fluoro-1-(D-3-mercapto-2-methylpropanoyl)-DL-proline.

Eksempel 31Example 31

cis- 3- klor- l-( D- 3- merkapto- 2- metylpropanoyl- L- prolincis- 3- chloro- l-( D- 3- mercapto- 2- methylpropanoyl- L- proline

Ved å anvende cis-3-klor-L-prolin [erholdt fra 3-hydroksy-prolin ved fremgangsmåten beskrevet i Aust. J. Chem. 20, 149 3 By using cis-3-chloro-L-proline [obtained from 3-hydroxy-proline by the method described in Aust. J. Chem. 20, 149 3

(1967)] istedenfor cis-4-fluor-L-prolin-hydrobromid ved fremgangsmåten ifølge eksempel 20 og derefter underkaste produktet fremgangsmåten ifølge eksempel 21, får man cis-1-[D-3-(acetyltio)-2-metylpropanoyl-3-klor-L-prolin og c.is-3-klor-l- (D-3-merkapto-2- metylpropanoyl)-L-prolin. (1967)] instead of cis-4-fluoro-L-proline hydrobromide in the method according to Example 20 and then subjecting the product to the method according to Example 21, one obtains cis-1-[D-3-(acetylthio)-2-methylpropanoyl-3 -chloro-L-proline and c,is-3-chloro-1-(D-3-mercapto-2-methylpropanoyl)-L-proline.

Eksempel 32Example 32

4, 4- diklor- l-( D- 3- merkapto- 2- metylpropanoyl)- L- prolin4, 4- dichloro- l-( D- 3- mercapto- 2- methylpropanoyl)- L- proline

Ved å anvende 4,4-diklor-L-prolin [fremstilt fra 4-keto-L-prolin-diketopiperazin og fosforpentaklorid ved fremgangsmåten beskrevet i J. Med. Chem. 20, 1176 (1977)] istedenfor cis-4-fluor-L-prolin-hydrobromid ved fremgangsmåten ifølge eksempel 20, og derefter underkaste produktet fremgangsmåten ifølge eksempel 21, får man 1-[D-3-(acetyltio)-2-metylpropanoyl]-4,4-diklor-L-prolin og 4,4-diklor-l-(D-3-merkapto-2-metylpropanoyl)-L-prolin. By using 4,4-dichloro-L-proline [prepared from 4-keto-L-proline-diketopiperazine and phosphorus pentachloride by the method described in J. Med. Chem. 20, 1176 (1977)] instead of cis-4-fluoro-L-proline hydrobromide in the method according to Example 20, and then subjecting the product to the method according to Example 21, one obtains 1-[D-3-(acetylthio)-2-methylpropanoyl ]-4,4-dichloro-L-proline and 4,4-dichloro-1-(D-3-mercapto-2-methylpropanoyl)-L-proline.

Eksempel 33 Example 33

1, 1'-[ Ditiobis-( 2- D- metylpropanoyl)]- bis-[( cis- 4- fluor)- L- prolin] 1, 1'-[ Dithiobis-( 2- D- methylpropanoyl)]- bis-[( cis- 4- fluoro)- L- proline]

Ved å anvende cis-4-fluor-1-(D-3-merkapto-2-metylpropanoyl)-L-prolin istedenfor 1-(3-merkapto-2-trifluormetylpropanoyl ) -L-prolin ved fremgangsmåten ifølge eksempel 9, får man 1,1'-[ditiobis-(2-D-metylpropanoyl)]-bis-[(cis-4-fluor)-L-prolin]. By using cis-4-fluoro-1-(D-3-mercapto-2-methylpropanoyl)-L-proline instead of 1-(3-mercapto-2-trifluoromethylpropanoyl)-L-proline in the method according to example 9, one obtains 1,1'-[dithiobis-(2-D-methylpropanoyl)]-bis-[(cis-4-fluoro)-L-proline].

Eksempel 34Example 34

4, 4- difluor- 1-( 3- merkaptobutanoy1)- L- prolin4, 4-difluoro-1-(3-mercaptobutanoyl)-L-proline

Ved å anvende 3-acetyltiobutansyreklorid istedenfor 3- acetyltio-2-trifluormetylpropansyreklorid ved fremgangsmåten ifølge eksempel 11 og derefter underkaste produktet fremgangsmåten ifølge eksempel 12, får man 1-(3-acetyltiobutanoyl)-4,4-difluor-L-prolin og 4,4-difluor-1-(3-merkaptobutanoyl)-L-prolin. By using 3-acetylthiobutanoic acid chloride instead of 3-acetylthio-2-trifluoromethylpropanoic acid chloride in the method according to example 11 and then subjecting the product to the method according to example 12, one obtains 1-(3-acetylthiobutanoyl)-4,4-difluoro-L-proline and 4, 4-difluoro-1-(3-mercaptobutanoyl)-L-proline.

Eksempel 35Example 35

1-( 3- propanoyltio- 2- trifluormetylpropanoyl)- L- prolin1-(3-propanoylthio-2-trifluoromethylpropanoyl)-L-proline

Ved å anvende tiopropansyre istedenfor tioeddiksyreBy using thiopropanoic acid instead of thioacetic acid

ved fremgangsmåten ifølge eksempel 1, og derefter underkaste by the method according to example 1, and then submit

produktet fremgangsmåtene ifølge eksemplene 2 og 3, får man henholdsvis 3-propanoyltio-2-trifluormetylpropansyre, 1-(3-propanoyltio-2-trifluormetylpropanoyl)-L-prolin-tert.butylester og 1-(3-propanoyltio-2-trifluormetylpropanoyl)-L-prolin. the product the methods according to examples 2 and 3, 3-propanoylthio-2-trifluoromethylpropanoyl, 1-(3-propanoylthio-2-trifluoromethylpropanoyl)-L-proline tert-butyl ester and 1-(3-propanoylthio-2-trifluoromethylpropanoyl) are obtained respectively -L-proline.

Eksempel 36Example 36

3-( 4- metoksybenzyl)- tio- 2- tri fluormetylpropansyre3-(4-Methoxybenzyl)-thio-2-trifluoromethylpropanoic acid

En jevn blanding av 1-trifluormetylakrylsyre (3,9 g)A uniform mixture of 1-trifluoromethylacrylic acid (3.9 g)

og 4-metoksybenzyltiol (4,3 g) omrøres ved 100-110° i 1 time. Blandingen får avkjøles til romtemperatur, og det faste stoff omkrystalliseres fra cykloheksan, sm.p. 72-74°. and 4-methoxybenzylthiol (4.3 g) is stirred at 100-110° for 1 hour. The mixture is allowed to cool to room temperature, and the solid is recrystallized from cyclohexane, m.p. 72-74°.

Eksempel 37 Example 37

1-[ 3-( 4- metoksybenzyl) tio- 2- trifluormetylpropanoyl)- L- prolin-tert- butylester 1-[ 3-( 4- methoxybenzyl) thio- 2- trifluoromethylpropanoyl)- L- proline tert- butyl ester

En oppløsning av 3-(4-metoksybenzyl)tio-2-trifluormetylpropansyre (6,5 g) og prolin-tert-butylester (3,76 g) i diklormetan (500 ml) omrøres ved 0° og behandles med dicykloheksylkarbodiimid (4,53 g). Efter 30 minutter ved 0° og natten over ved romtemperatur, filtreres blandingen, og filtratet vaskes nøytralt. Det organiske lag tørres og konsentreres til tørrhet i vakuum. TLC [silikagel, metylenklorid/etylacetat (95:5)] viser to hovedflekker, Rf 0,46 og 0,51, svarende til de to diastereoisomerer. A solution of 3-(4-methoxybenzyl)thio-2-trifluoromethylpropanoic acid (6.5 g) and proline tert-butyl ester (3.76 g) in dichloromethane (500 ml) is stirred at 0° and treated with dicyclohexylcarbodiimide (4, 53 g). After 30 minutes at 0° and overnight at room temperature, the mixture is filtered, and the filtrate is washed neutrally. The organic layer is dried and concentrated to dryness in vacuo. TLC [silica gel, methylene chloride/ethyl acetate (95:5)] shows two main spots, Rf 0.46 and 0.51, corresponding to the two diastereoisomers.

Eksempel 38Example 38

1-( 3- merkapto- 2- trifluormetylpropanoyl)- L- prolin1-(3-mercapto-2-trifluoromethylpropanoyl)-L-proline

En oppløsning av 1-[3- (4-metoksybenzyl)tio-2-trifluormety lpropanoyl)-L-prolin-tert-butylester (4,47 g) erholdt i eksempel 37, og anisol (10 ml) avkjøles til 0°, og trifluoreddiksyre (100 ml)' tilsettes, fulgt av kvikksølv(II)acetat (3,18 g). Badet fjernes, og blandingen omrøres ved romtemperatur i 1 time. Blandingen konsentreres til tørrhet i vakuum, og residuet utgnies med eter-heksan. Det uoppløselige materiale suspenderes i vann,, og hydrogensulfid bobles gjennom i 10 minutter. Bunnfallet fjernes ved filtrering, og filtratet frysetørres for A solution of 1-[3-(4-methoxybenzyl)thio-2-trifluoromethylpropanoyl)-L-proline tert-butyl ester (4.47 g) obtained in Example 37 and anisole (10 ml) is cooled to 0°, and trifluoroacetic acid (100 ml)' are added, followed by mercuric (II) acetate (3.18 g). The bath is removed, and the mixture is stirred at room temperature for 1 hour. The mixture is concentrated to dryness in vacuo, and the residue is triturated with ether-hexane. The insoluble material is suspended in water, and hydrogen sulphide is bubbled through for 10 minutes. The precipitate is removed by filtration, and the filtrate is freeze-dried

å gi produktet, 1-(3-merkapto-2-trifluormetylpropanoyl)-L-prolin som.et amorft, fast stoff. Rf 0,29-0,31 (silikagel - benzen: to give the product, 1-(3-mercapto-2-trifluoromethylpropanoyl)-L-proline as an amorphous solid. Rf 0.29-0.31 (silica gel - benzene:

eddiksyre 7:1).acetic acid 7:1).

Eksempel 39Example 39

3- acetyltio- 2- klorpropansyreklorid3- acetylthio- 2- chloropropanoic acid chloride

Ved å anvende 2-klorakrylsyre istedenfor 2-trifluormetylakrylsyre ved fremgangsmåten ifølge eksempel 1 og derefter la produktet reagere med tionylklorid, får man 3-acetyltio-2-klor-propansyre og 3-acetyltio-2-klorpropansyreklorid. By using 2-chloroacrylic acid instead of 2-trifluoromethylacrylic acid in the method according to example 1 and then allowing the product to react with thionyl chloride, 3-acetylthio-2-chloropropanoic acid and 3-acetylthio-2-chloropropanoic acid chloride are obtained.

Eksempel 40 Example 40

D- 3- acetyltio- 2- metylpropansyrekloridD- 3- acetylthio- 2- methylpropanoic acid chloride

En suspensjon av 1-(D-3-merkapto-2-metylpropanoyl)-L-prolin (150 g, 690 mmol) i 1274 ml vann og 426 ml konsentrert saltsyre (5,526 mol) tilbakeløpsbehandles under nitrogen under omrøring i 8 timer. Den resulterende oppløsning holdes ved romtemperatur natten over og ekstraheres derefter med 400 ml kloroform (10 x) . De samlede kloroformekstrakter tørres over. magnesiumsulfat under nitrogen og inndampes derefter. Til residuet, 81,2 g, settes eddiksyreanhydrid (176 ml/1,809 mol) og pyridin, 180 ml, og blandingen holdes ved romtemperatur i 20 timer. Blandingen inndampes derefter og det oljeaktige residuum oppløses A suspension of 1-(D-3-mercapto-2-methylpropanoyl)-L-proline (150 g, 690 mmol) in 1274 mL of water and 426 mL of concentrated hydrochloric acid (5.526 mol) is refluxed under nitrogen with stirring for 8 h. The resulting solution is kept at room temperature overnight and then extracted with 400 ml of chloroform (10x). The combined chloroform extracts are dried over. magnesium sulfate under nitrogen and then evaporated. To the residue, 81.2 g, are added acetic anhydride (176 ml/1.809 mol) and pyridine, 180 ml, and the mixture is kept at room temperature for 20 hours. The mixture is then evaporated and the oily residue dissolved

i 1000 ml etylacetat, og oppløsningen vaskes i rekkefølge med 200 ml 5%ig saltsyre-mettet natriumklorid (vaskevæsker pH 2), in 1000 ml of ethyl acetate, and the solution is washed successively with 200 ml of 5% hydrochloric acid-saturated sodium chloride (wash liquids pH 2),

200 ml mettet natriumkloridoppløsning (2 ganger, annen vaskevæske, pH 7), og derefter avdrives oppløsningsmidlet. Til det klare, oljeaktige residuum, [96,9 g, 86,5%, la]^ 5 = -61,8° (CHC13)] settes nydestillert tionylklorid (83 ml, 1,173 mol), og den resulterende oppløsning omrøres ved romtemperatur med gass-utvikling i 18 timer. Overskudd av tionylklorid avdampes under vakuum med et 50° bad, og residuet destilleres ved redusert trykk for å oppnå 56,9 g D-3-acetyltio-2-metylpropansyreklorid, k.p. 40-4° . (0,17-0,2 mm Hg) , [a]p<5->42,5° (c 2, metanol) . 200 ml of saturated sodium chloride solution (2 times, other washing liquid, pH 7), and then the solvent is evaporated. To the clear, oily residue, [96.9 g, 86.5%, la]^ 5 = -61.8° (CHCl 3 )] is added freshly distilled thionyl chloride (83 ml, 1.173 mol) and the resulting solution is stirred at room temperature with gas development for 18 hours. Excess thionyl chloride is evaporated under vacuum with a 50° bath, and the residue is distilled at reduced pressure to obtain 56.9 g of D-3-acetylthio-2-methylpropanoic acid chloride, b.p. 40-4°. (0.17-0.2 mm Hg) , [α]p<5->42.5° (c 2, methanol) .

Eksempel 41Example 41

3- acetyltio- 2- brompropansyreklorid3- acetylthio- 2- bromopropanoic acid chloride

Ved å anvende 2-bromakrylsyre istedenfor 2-trifluormetylakrylsyre ved fremgangsmåten ifølge eksempel 1 og derefter la produktet reagere med tionylklorid, får man 3-acetyltio-2-brom-propansyre og 3-acetyltio-2-brompropansyreklorid. By using 2-bromoacrylic acid instead of 2-trifluoromethylacrylic acid in the method according to example 1 and then allowing the product to react with thionyl chloride, 3-acetylthio-2-bromopropanoic acid and 3-acetylthio-2-bromopropanoic acid chloride are obtained.

Eksempel 4 2 Example 4 2

Trans- 1-[ D- 3-( acetyltio)- 2- metyl- l- oksopropyl]- 4- fluor- L- prolinTrans- 1-[ D- 3-( acetylthio)- 2- methyl- l- oxopropyl]- 4- fluoro- L- proline

A) Trans- 1- karbobenzyloks. y- 4- f luor- L- prolinA) Trans-1- carbobenzylox. y- 4- fluoro- L- proline

En oppløsning av 6,2 g trans-l-karbobenzyloksy-4-fluor-L-prolin-metylester i 50 ml metanol behandles dråpevis ved 0-5° med 11,5 ml 2N natriumhydroksydoppløsning, og efter 1 time ved 0° får den oppvarmes til romtemperatur natten over.. Reaksjonsblandingen konsentreres under redusert trykk til ca. halvparten av sitt opprinnelige volum og fortynnes derefter med 100 ml vann. Den vandige reaksjonsblandingen ekstraheres med eter, og eterekstraktene kastes. Den vandige oppløsning surgjøres under avkjøling med fortynnet saltsyre til pH 2 og ekstraheres derefter med etylacetat (4 x 50 ml). De samlede etylacetatekstrakter tørres over vannfritt magnesiumsulfat og konsentreres derefter under redusert trykk for å gi det ønskede produkt. A solution of 6.2 g of trans-1-carbobenzyloxy-4-fluoro-L-proline methyl ester in 50 ml of methanol is treated dropwise at 0-5° with 11.5 ml of 2N sodium hydroxide solution, and after 1 hour at 0° it obtains is heated to room temperature overnight. The reaction mixture is concentrated under reduced pressure to approx. half of its original volume and then diluted with 100 ml of water. The aqueous reaction mixture is extracted with ether, and the ether extracts are discarded. The aqueous solution is acidified under cooling with dilute hydrochloric acid to pH 2 and then extracted with ethyl acetate (4 x 50 ml). The combined ethyl acetate extracts are dried over anhydrous magnesium sulfate and then concentrated under reduced pressure to give the desired product.

Det renses ved omdannelse til cykloheksylaminsaltet, sm.p. 194-196°, [a]° -44° (c = 1% i metanol). It is purified by conversion to the cyclohexylamine salt, m.p. 194-196°, [α]° -44° (c = 1% in methanol).

Den frie syre erholdes ved suspendering av cykloheksylaminsaltet i' 25 ml etylacetat med 22 ml N saltsyre og ekstraksjon av det vandige lag med 4 x .35 ml etylacetat. De samlede etylacetatekstrakter tørres over vannfritt magnesiumsulfat, og oppløsningsmidlet konsentreres under redusert trykk for å gi den ønskede trans-l-karbobenzyloksy-4-fluor-L-prolin. The free acid is obtained by suspending the cyclohexylamine salt in 25 ml of ethyl acetate with 22 ml of N hydrochloric acid and extracting the aqueous layer with 4 x 35 ml of ethyl acetate. The combined ethyl acetate extracts are dried over anhydrous magnesium sulfate, and the solvent is concentrated under reduced pressure to give the desired trans-1-carbobenzyloxy-4-fluoro-L-proline.

B) Trans- 4- fluor- L- prolin- hydrobromidB) Trans-4-fluoro-L-proline hydrobromide

En blanding av 3 g trans-l-karbobenzyloksy-4-fluor-L-prolin og 15 ml hydrogenbromid i eddiksyre (30-32%) omrøres A mixture of 3 g of trans-1-carbobenzyloxy-4-fluoro-L-proline and 15 ml of hydrogen bromide in acetic acid (30-32%) is stirred

i 1 time, og derefter tilsettes 150 ml vannfri eter. Oppløsnings-midlet dekanteres fra bunnfallet som derefter utgnis med frisk eter og til slutt med metyletylketon. Trans-4-fluor-L-prolin-hydrobromidet smelter ved 162-164° (spaltn.), [cx]^ -30° for 1 hour, and then 150 ml of anhydrous ether are added. The solvent is decanted from the precipitate, which is then triturated with fresh ether and finally with methyl ethyl ketone. The trans-4-fluoro-L-proline hydrobromide melts at 162-164° (dec.), [cx]^ -30°

(c = 1% i metanol).(c = 1% in methanol).

C) Trans- 1-[ D- 3-( acetyltio)- 2- metyl- l- oksopropyl]- 4- fluor-L- prolin C) Trans- 1-[ D- 3-( acetylthio)- 2- methyl- l- oxopropyl]- 4- fluoro-L- proline

Til en omrørt oppløsning av 1,9 g trans-4-fluor-L-prolin-hydrobromid i 25 ml kaldt vann settes 1 g natriumkarbonat for å regulere pH til 8,2. Under fortsatt avkjøling (5°) og omrøring tilsettes derefter dråpevis 1,8 g D-3-acetyltio-2-metylpropionyl-klorid i 2,5 ml eter mens pH holdes ved ca. 8,2-8,3 ved dråpevis tilsetning av en 25%ig vandig natriumkarbonatoppløsnihg. Omrøringen og avkjølingen fortsettes i 1 time efter at tilsetningen er fullført. Reaksjonsblandingen ekstraheres med etylacetat (2 x 25 ml), og ekstraktene kastes. Til. det vandige lag settes 50 ml etylacetat, og med omrøring og avkjøling tilsettes konsentrert saltsyre dråpevis til en pH på 2,0. Det vandige lag mettes med natriumklorid, og etylacetatlaget fraskilles. To a stirred solution of 1.9 g of trans-4-fluoro-L-proline hydrobromide in 25 ml of cold water is added 1 g of sodium carbonate to adjust the pH to 8.2. During continued cooling (5°) and stirring, 1.8 g of D-3-acetylthio-2-methylpropionyl chloride in 2.5 ml of ether are then added dropwise while the pH is kept at approx. 8.2-8.3 by dropwise addition of a 25% aqueous sodium carbonate solution. Stirring and cooling are continued for 1 hour after the addition is complete. The reaction mixture is extracted with ethyl acetate (2 x 25 ml), and the extracts are discarded. To. 50 ml of ethyl acetate are added to the aqueous layer, and with stirring and cooling, concentrated hydrochloric acid is added dropwise to a pH of 2.0. The aqueous layer is saturated with sodium chloride, and the ethyl acetate layer is separated.

Det vandige lag ekstraheres med ytterligere etylacetat (3 x 25 ml)., og de samlede etylacetatekstrakter tørres over vannfritt magensium-sulfat og konsentreres under redusert trykk for å gi det ønskede produkt. Dicykloheksylaminsaltet fremstilles ved oppløsning av produktet i 25 ml etylacetat og tilsetning av en oppløsning, av 1,8 g dicykloheksylamin i 35 ml etylacetat. Det utfelte salt filtreres og omkrystalliseres fra isopropanol for å gi dicykloheksylaminsaltet av trans-1-[D-3-(acetyltio)-2-metyl-l-oksopropyl]-4-fluor-L-prolin, sm.p. 209-211°, [a]^<5>-85° (c = 1% metanol). The aqueous layer is extracted with additional ethyl acetate (3 x 25 mL), and the combined ethyl acetate extracts are dried over anhydrous magnesium sulfate and concentrated under reduced pressure to give the desired product. The dicyclohexylamine salt is prepared by dissolving the product in 25 ml of ethyl acetate and adding a solution of 1.8 g of dicyclohexylamine in 35 ml of ethyl acetate. The precipitated salt is filtered and recrystallized from isopropanol to give the dicyclohexylamine salt of trans-1-[D-3-(acetylthio)-2-methyl-1-oxopropyl]-4-fluoro-L-proline, m.p. 209-211°, [α]^<5>-85° (c = 1% methanol).

Den frie syre utvinnes ved å oppløse dicykloheksylaminsaltet The free acid is recovered by dissolving the dicyclohexylamine salt

. i 5%ig vandig kaliumhydrogensulfat og ekstrahere med etylacetat. Etylacetatoppløsningen tørres over vannfritt magnesiumsulfat . in 5% aqueous potassium hydrogen sulphate and extract with ethyl acetate. The ethyl acetate solution is dried over anhydrous magnesium sulfate

og konsentreres under redusert trykk for å gi den ønskede trans-1-[D-3-(acetyltio)-2-metyl-l-oksopropyl]-4-fluor-L-prolin. and concentrated under reduced pressure to give the desired trans-1-[D-3-(acetylthio)-2-methyl-1-oxopropyl]-4-fluoro-L-proline.

Eksempel 4 3 Example 4 3

trans- 4- fluor- 1-( D- 3- merkapto- 2- metyl- l- oksopropyl)- L- prolin trans- 4- fluoro- 1-( D- 3- mercapto- 2- methyl- l- oxopropyl)- L- proline

Argon føres gjennom en kald oppløsning av 4,2 ml konsentrert ammoniumhydroksyd i 16 ml vann. Til denne oppløsning settes, med omrøring.i en atmosfære av argon, 1,8 g trans-1-[D-3-(acetyltio)-2-metyl-l-oksopropyl]-4-fluor-L-prolin. Reaksjonsblandingen omrøres i ytterligere 2 timer og ekstraheres derefter med etylacetat som kastes. Det vandige lag omrøres, Argon is passed through a cold solution of 4.2 ml of concentrated ammonium hydroxide in 16 ml of water. To this solution is added, with stirring in an atmosphere of argon, 1.8 g of trans-1-[D-3-(acetylthio)-2-methyl-1-oxopropyl]-4-fluoro-L-proline. The reaction mixture is stirred for a further 2 hours and then extracted with ethyl acetate which is discarded. The aqueous layer is stirred,

30 ml etylacetat tilsettes, og det vandige lag surgjøres med 30 ml of ethyl acetate are added, and the aqueous layer is acidified with

konsentrert saltsyre. Det vandige lag mettes med natriumklorid, og etylacetatlaget fraskilles. Det vandige lag ekstraheres med etylacetat (3 x 30 ml). De samlede etylacetatekstrakter tørres over vannfritt magnesiumsulfat og konsentreres under redusert trykk for å gi den ønskede trans-4-fluor-1-[D-3-merkapto-2-metyl-1-oksopropyl) -L-prolin, [ot]D 26 -112 o (c = 1% i metanol). concentrated hydrochloric acid. The aqueous layer is saturated with sodium chloride, and the ethyl acetate layer is separated. The aqueous layer is extracted with ethyl acetate (3 x 30 ml). The combined ethyl acetate extracts are dried over anhydrous magnesium sulfate and concentrated under reduced pressure to give the desired trans-4-fluoro-1-[D-3-mercapto-2-methyl-1-oxopropyl)-L-proline, [ot]D 26 -112 o (c = 1% in methanol).

Eksempel 4 4 Example 4 4

1-[ D- 3-( acetyltio)- 2- metyl- l- oksopropyl]- 4, 4- difluor- L- prolin A) 1- karbobenzyloksy- 4, 4- difluor- L- prolin- metylester 1-[ D- 3-( acetylthio)- 2- methyl- l- oxopropyl]- 4, 4- difluoro- L- proline A) 1- carbobenzyloxy- 4, 4- difluoro- L- proline- methyl ester

Til en avkjølt omrørt oppløsning av 3,3 g 1-karbobenzyloksy-4-keto-L-prolin-metylester i 80 ml metylendiklorid settes dråpevis 3,3 ml dietylaminosvoveltrifluorid. Reaksjonsblandingen får stå natten over ved romtemperatur. Ca. 100 g knust is til- To a cooled, stirred solution of 3.3 g of 1-carbobenzyloxy-4-keto-L-proline methyl ester in 80 ml of methylene dichloride, 3.3 ml of diethylaminosulphur trifluoride is added dropwise. The reaction mixture is allowed to stand overnight at room temperature. About. 100 g crushed ice for

settes under omrøring, og reaksjonsblandingen omrøres i 45 minutter. Det organiske lag fraskilles, og det vandige lag ekstraheres med metylenklorid (2 x 40 ml). De samlede ekstrakter tørres over vannfritt magnesiumsulfat og konsentreres derefter under redusert trykk for å gi den ønskede 1-karbobenzyloksy-4,4-difluor-L-prolin-metylester. is stirred, and the reaction mixture is stirred for 45 minutes. The organic layer is separated, and the aqueous layer is extracted with methylene chloride (2 x 40 ml). The combined extracts are dried over anhydrous magnesium sulfate and then concentrated under reduced pressure to give the desired 1-carbobenzyloxy-4,4-difluoro-L-proline methyl ester.

B) l- karbobenzyloksy- 4, 4- difluor- L- prolinB) l-carbobenzyloxy-4,4-difluoro-L-proline

En oppløsning av 5,6 g l-karbobenzyloksy-4,4-difluor-L-prolin-metylester i 50 ml metanol behandles dråpevis med A solution of 5.6 g of 1-carbobenzyloxy-4,4-difluoro-L-proline methyl ester in 50 ml of methanol is treated dropwise with

11,5 ml 2N natriumhydroksydoppløsning ved 0-5°. Reaksjonsblandingen får stå ved 0° i 1 time og oppvarmes derefter til romtemperatur natten over. Reaksjonsblandingen konsentreres under redusert trykk til ca. halvparten av sitt opprinnelige volum og fortynnes derefter med 100 ml vann. Den vandige reaksjonsblanding ekstraheres med eter, og eterekstraktene kastes. Den vandige opp-løsning surgjøres med avkjøling med fortynnet saltsyre til pH 2 11.5 ml of 2N sodium hydroxide solution at 0-5°. The reaction mixture is allowed to stand at 0° for 1 hour and is then warmed to room temperature overnight. The reaction mixture is concentrated under reduced pressure to approx. half of its original volume and then diluted with 100 ml of water. The aqueous reaction mixture is extracted with ether, and the ether extracts are discarded. The aqueous solution is acidified by cooling with dilute hydrochloric acid to pH 2

og ekstraheres derefter med etylacetat (3 x 50 ml). Etylacetatekstraktene samles og vaskes med mettet natriumkloridoppløsning, tørres over vannfritt magnesiumsulfat og konsentreres for å gi det ønskede produkt, l-karbobenzyloksy-4,4-difluor-L-prolin. and then extracted with ethyl acetate (3 x 50 ml). The ethyl acetate extracts are combined and washed with saturated sodium chloride solution, dried over anhydrous magnesium sulfate and concentrated to give the desired product, 1-carbobenzyloxy-4,4-difluoro-L-proline.

Det renses ved omdannelse til cykloheksylaminsaltet, sm.p. 180-185°, [a]^<6>= -24° (c.= 1% i etanol). It is purified by conversion to the cyclohexylamine salt, m.p. 180-185°, [a]^<6>= -24° (c.= 1% in ethanol).

Den frie syre erholdes ved å behandle en vandig opp-løsning av cykloheksylaminsaltet med saltsyre og ekstrahere blandingen med etylacetat (4 x 30 ml). Etylacetatekstraktene tørres over vannfritt magnesiumsulfat og konsentreres under redusert trykk for å gi detønskede 1-karbobenzyloks.y-4 ,4-difluor-L-prolin. The free acid is obtained by treating an aqueous solution of the cyclohexylamine salt with hydrochloric acid and extracting the mixture with ethyl acetate (4 x 30 ml). The ethyl acetate extracts are dried over anhydrous magnesium sulfate and concentrated under reduced pressure to give the desired 1-carbobenzyloxy-4,4-difluoro-L-proline.

C) 4, 4- difluor- L- prolin- hydrobromidC) 4, 4-difluoro-L-proline hydrobromide

En blanding av 2,4 g 1-karbobenzyloksy-4,4-difluor-L-prolin og 12 ml hydrogenbromid i eddiksyre (30-32%) omrøres A mixture of 2.4 g of 1-carbobenzyloxy-4,4-difluoro-L-proline and 12 ml of hydrogen bromide in acetic acid (30-32%) is stirred

i 30 minutter ved romtemperatur, og derefter tilsettes 300 ml for 30 minutes at room temperature, and then add 300 ml

vannfri eter. Blandingen avkjøles, og det utfelte, faste stoff filtreres og tørres under redusert trykk. Det ønskede 4,4-difluor-L-prolin-hydrobromid smelter ved 16 3-165° (spaltn.), [ a]* 5 -14° (c =1%i metanol). anhydrous ether. The mixture is cooled, and the precipitated solid is filtered and dried under reduced pressure. The desired 4,4-difluoro-L-proline hydrobromide melts at 16 3-165° (dec.), [ a]* 5 -14° (c = 1% in methanol).

D) 1-[ D- 3-( acetyltio)- 2- metyl- l- oksopropyl]- 4, 4- difluor-L- prolin D) 1-[ D- 3-( acetylthio)- 2- methyl- l- oxopropyl]- 4, 4- difluoro-L- proline

Til en omrørt oppløsning av 2,7 g 4,4-difluor-L-prolin-hydrobromid i 30 ml vann, avkjølt til 5°, settes fast karbonat for å regulere pH til 8,4. Med fortsatt avkjøling og omrøring tilsettes derefter dråpevis 2,4 g D-3-acetyltio-2-metylpropionyl-klorid i 3 ml vannfri eter, mens oppløsningens pH-verdi holdes ved 8,1-8,3 ved tilsetning av en 25%ig vandig natriumkarbonat-oppløsning. Omrøringen og avkjølingen fortsettes i 1 time efter at tilsetningen er fullført. Reaksjonsblandingen ekstraheres med etylacetat (2 x 25 ml), og ekstraktene kastes. Til det vandige lag settes 50 ml etylacetat, og med omrøring og avkjøling tilsettes dråpevis konsentrert saltsyre til en pH på 2,0. Det vandige lag mettes med natriumklorid, og etylacetatlaget fraskilles. Det vandige lag ekstraheres med etylacetat (3 x 25 ml), og de samlede etylacetatekstrakter tørres over vannfritt magnesiumsulfat og konsentreres under redusert trykk for å gi det ønskede produkt. Dicykloheksylaminsaltet fremstilles ved å oppløse produktet i 40 ml etylacetat og tilsette en oppløsning av 2,3 g dicykloheksylamin i 5 ml etylacetat. Det utfelte salt filtreres og omkrystalliseres fra etanol. Dicykloheksylaminsaltet av 1-[D-3-(acetyltio)-2-metyl-l-oksopropyl]-4,4-difluor-L-prolin smelter ved 225-227°, [a]^<5>= -70° (c = 0,5% i metanol). To a stirred solution of 2.7 g of 4,4-difluoro-L-proline hydrobromide in 30 ml of water, cooled to 5°, solid carbonate is added to adjust the pH to 8.4. With continued cooling and stirring, 2.4 g of D-3-acetylthio-2-methylpropionyl chloride in 3 ml of anhydrous ether are then added dropwise, while the solution's pH value is kept at 8.1-8.3 by adding a 25% aqueous sodium carbonate solution. Stirring and cooling are continued for 1 hour after the addition is complete. The reaction mixture is extracted with ethyl acetate (2 x 25 ml), and the extracts are discarded. 50 ml of ethyl acetate is added to the aqueous layer, and with stirring and cooling, concentrated hydrochloric acid is added dropwise to a pH of 2.0. The aqueous layer is saturated with sodium chloride, and the ethyl acetate layer is separated. The aqueous layer is extracted with ethyl acetate (3 x 25 mL), and the combined ethyl acetate extracts are dried over anhydrous magnesium sulfate and concentrated under reduced pressure to give the desired product. The dicyclohexylamine salt is prepared by dissolving the product in 40 ml of ethyl acetate and adding a solution of 2.3 g of dicyclohexylamine in 5 ml of ethyl acetate. The precipitated salt is filtered and recrystallized from ethanol. The dicyclohexylamine salt of 1-[D-3-(acetylthio)-2-methyl-l-oxopropyl]-4,4-difluoro-L-proline melts at 225-227°, [a]^<5>= -70° ( c = 0.5% in methanol).

Den frie syre utvinnes ved å oppløse dicykloheksylaminsaltet i 5%ig vandig kaliumhydrogensulfat og ekstrahere med etylacetat. Etylacetatoppløsningen tørres over vannfritt magnesiumsulfat og konsentreres under redusert trykk for å gi det ønskede 1-[D-3-(acetyltio)-2-metyl-l-oksopropyl]-4,4-difluor-L-prolin. The free acid is recovered by dissolving the dicyclohexylamine salt in 5% aqueous potassium hydrogen sulphate and extracting with ethyl acetate. The ethyl acetate solution is dried over anhydrous magnesium sulfate and concentrated under reduced pressure to give the desired 1-[D-3-(acetylthio)-2-methyl-1-oxopropyl]-4,4-difluoro-L-proline.

Eksempel 45 Example 45

4, 4- difluor- 1-( D- 3- merkapto- 2- metyl- l- oksopropyl)- L- prolin4, 4- difluoro- 1-( D- 3- mercapto- 2- methyl- l- oxopropyl)- L- proline

Argon føres gjennom en kald oppløsning av 4,6 ml konsentrert ammoniumhydroksyd i 11 ml vann. Til denne oppløsning settes, med omrøring i en atmosfære av argon, 2,1 g l-[D-3-(acetyltio)-2-metyl-l-oksopropyl]-4,4-difluor-L-prolin. Reaksjonsblandingen omrøres ytterligere 2 timer og ekstraheres derefter med etylacetat som kastes. Det vandige lag omrøres, 30 ml etylacetat tilsettes, og det vandige lag surgjøres med konsentrert saltsyre. Det vandige lag mettes med natriumklorid, og etylacetatlaget fraskilles. Det vandige lag ekstraheres med etylacetat (3 x 25 ml). De samlede etylacetatekstrakter tørres over vannfritt magnesiumsulfat og konsentreres under redusert trykk for å gi det ønskede 4,4-difluor-1-(D-3-merkapto-2-mety1-1-oksopropyl)-L-prqlin. Argon is passed through a cold solution of 4.6 ml of concentrated ammonium hydroxide in 11 ml of water. To this solution is added, with stirring in an atmosphere of argon, 2.1 g of 1-[D-3-(acetylthio)-2-methyl-1-oxopropyl]-4,4-difluoro-L-proline. The reaction mixture is stirred for a further 2 hours and then extracted with ethyl acetate which is discarded. The aqueous layer is stirred, 30 ml of ethyl acetate is added, and the aqueous layer is acidified with concentrated hydrochloric acid. The aqueous layer is saturated with sodium chloride, and the ethyl acetate layer is separated. The aqueous layer is extracted with ethyl acetate (3 x 25 ml). The combined ethyl acetate extracts are dried over anhydrous magnesium sulfate and concentrated under reduced pressure to give the desired 4,4-difluoro-1-(D-3-mercapto-2-methyl-1-oxopropyl)-L-prqline.

Eksempel 46 Example 46

1-[ D- 3-( acetyltio)- 2- metyl- l- oksopropyl]- 5- fluor- 2- pipekolsyre A) l- karbobenzyloksy- 5- hydroksy- L- pipekolsyre- metylester 1-[ D- 3-( acetylthio)- 2- methyl- l- oxopropyl]- 5- fluoro- 2- pipecolic acid A) l- carbobenzyloxy- 5- hydroxy- L- pipecolic acid methyl ester

En oppløsning av 5 g 1-karbobenzyloksy-5-hydroksy-L-pipekolsyre i- 60 ml dioksan behandles med en eterisk oppløsning av diazometan porsjonsvis, inntil den gule farve holder seg. Temperaturen holdes ved ca. 5° under tilsetningen. Overskudd av diazometan nedbrytes med iseddik, og den resulterende oppløsning tørres over vannfritt magnesiumsulfat. Oppløsningen konsentreres under redusert trykk for å gi den ønskede 1-karbobenzyloksy-5-hydroksy-L-pipekolsyre-metylester som en blekgul, viskøs olje. A solution of 5 g of 1-carbobenzyloxy-5-hydroxy-L-pipecolic acid in 60 ml of dioxane is treated with an ethereal solution of diazomethane in portions, until the yellow color remains. The temperature is kept at approx. 5° during the addition. Excess diazomethane is decomposed with glacial acetic acid, and the resulting solution is dried over anhydrous magnesium sulfate. The solution is concentrated under reduced pressure to give the desired 1-carbobenzyloxy-5-hydroxy-L-pipecolic acid methyl ester as a pale yellow viscous oil.

B) 1- karbobenzyloksy- 5- tosyloksy- L- pipekolsyre- metylester B) 1-carbobenzyloxy-5-tosyloxy-L-pipecolic acid methyl ester

Til en omrørt oppløsning av 5,7 g 1-karbobenzyloksy-5-hydroksy-L-pipekolsyre-metylester i 12 ml pyridin settes dråpevis ved 5 til 8° en oppløsning av 4 g tosylklorid i 6 ml pyridin. Reaksjonsblandingen holdes ved 5° i 72 timer og behandles derefter med avkjøling, med 200 ml iskald 2N saltsyre. Bunnfallet opp-løses i kloroform,, og den vandige oppløsning ekstraheres med ytterligere kloroform (3 x 75 ml). De samlede kloroform-oppløsninger tørres over vannfritt magnesiumsulfat og konsentreres under redusert trykk for å gi den ønskede l-karbobenzyloksy-5-tosyloksy-L-pipekolsyre-metylester, som smelter ved 74-76° efter krystallisering fra isopropanol, [ct]^ = -5°, c = 1% i metanol, [a]D 2 6 = -11 o, C = 1% i kloroform. To a stirred solution of 5.7 g of 1-carbobenzyloxy-5-hydroxy-L-pipecolic acid methyl ester in 12 ml of pyridine is added dropwise at 5 to 8° a solution of 4 g of tosyl chloride in 6 ml of pyridine. The reaction mixture is kept at 5° for 72 hours and is then treated, with cooling, with 200 ml of ice-cold 2N hydrochloric acid. The precipitate is dissolved in chloroform, and the aqueous solution is extracted with further chloroform (3 x 75 ml). The combined chloroform solutions are dried over anhydrous magnesium sulfate and concentrated under reduced pressure to give the desired l-carbobenzyloxy-5-tosyloxy-L-pipecolic acid methyl ester, which melts at 74-76° after crystallization from isopropanol, [ct]^ = -5°, c = 1% in methanol, [a]D 2 6 = -11 o, C = 1% in chloroform.

C) l- karbobenzyloksy- 5- fluor- L- pipekolsyre- metylesterC) l-carbobenzyloxy-5-fluoro-L-pipecolic acid methyl ester

En omrørt suspensjon av 5,2 g 1-karbobenzyloksy-5-tosyloksy-L-pipekolsyre-metylester i 50 ml dietylenglykol behandles med 5,2 g vannfritt kaliumfluorid, og blandingen oppvarmes ved 80°C med omrøring i 14 timer. Den avkjølte oppløsning fortynnes med 50 ml vann og ekstraheres med etylacetat (3 x 100 ml). Etylacetatekstraktene samles, vaskes med en mettet natriumklorid-oppløsning og tørres over vannfritt magnesiumsulfat. Oppløsnings-midlet fjernes under redusert trykk for å gi den ønskede 1-karbobenzyloksy-5-flupr-L-pipekolsyre-metylester som en gul olje. A stirred suspension of 5.2 g of 1-carbobenzyloxy-5-tosyloxy-L-pipecolic acid methyl ester in 50 ml of diethylene glycol is treated with 5.2 g of anhydrous potassium fluoride, and the mixture is heated at 80° C. with stirring for 14 hours. The cooled solution is diluted with 50 ml of water and extracted with ethyl acetate (3 x 100 ml). The ethyl acetate extracts are combined, washed with a saturated sodium chloride solution and dried over anhydrous magnesium sulfate. The solvent is removed under reduced pressure to give the desired 1-carbobenzyloxy-5-flupr-L-pipecolic acid methyl ester as a yellow oil.

D) 1- karbobenzyloksy- 5- fluor- L- pipekolsyreD) 1-carbobenzyloxy-5-fluoro-L-pipecolic acid

Til en avkjølt (0°) oppløsning av 4,6 g 1-karbobenzyloksy-5-fluor-L-pipekolsyre-metylester i 32 ml metanol settes 7,3 ml To a cooled (0°) solution of 4.6 g of 1-carbobenzyloxy-5-fluoro-L-pipecolic acid methyl ester in 32 ml of methanol is added 7.3 ml

2N natriumhydroksydoppløsning. Reaksjonsblandingen får holde2N sodium hydroxide solution. The reaction mixture is allowed to stand

. seg ved 0-5° i 1 time, og ved romtemperatur natten over. Oppløsningen konsentreres til ca. halvparten av sitt opprinnelige volum under redusert trykk, og fortynnes med 20 ml vann. Opp-løsningen ekstraheres med eter, som kastes. Den vandige opp-løsning avkjøles, surgjøres med konsentrert saltsyre og ekstraheres med etylacetat (3 x 50 ml). De samlede etylacetatekstrakter tørres over vannfritt magnesiumsulfat og konsentreres under redusert trykk for å gi den ønskede l-karbobenzyloksy-5-fluor-L-pipekolsyre . Den renses ved omdannelse til cykloheksylaminsaltet som smelter ved 158-161°, [a]D = -11° (c = 1% i metanol). . at 0-5° for 1 hour, and at room temperature overnight. The solution is concentrated to approx. half of its original volume under reduced pressure, and diluted with 20 ml of water. The solution is extracted with ether, which is discarded. The aqueous solution is cooled, acidified with concentrated hydrochloric acid and extracted with ethyl acetate (3 x 50 ml). The combined ethyl acetate extracts are dried over anhydrous magnesium sulfate and concentrated under reduced pressure to give the desired 1-carbobenzyloxy-5-fluoro-L-pipecolic acid. It is purified by conversion to the cyclohexylamine salt which melts at 158-161°, [a]D = -11° (c = 1% in methanol).

Den frie syre erholdes ved å behandle en vandig oppløsning av saltet med saltsyre, ekstrahere blandingen med etylacetat (4 x 25 ml) og konsentrere de tørrede ekstrakter under redusert trykk. The free acid is obtained by treating an aqueous solution of the salt with hydrochloric acid, extracting the mixture with ethyl acetate (4 x 25 ml) and concentrating the dried extracts under reduced pressure.

E) 5- f luor- L- pipekolsyre.- hydrobromidE) 5-fluoro-L-pipecolic acid.- hydrobromide

En blanding av 2,2 g l-karbobenzyloksy-5-fluor-L-pipekolsyre og 12 ml hydrogenbromid i eddiksyre (30-32%) omrøres i 30 minutter ved romtemperatur, og derefter tilsettes 300 ml vannfri eter. Den avkjølte blanding filtreres, og det utfelte, faste stoff tørres under redusert.trykk for å gi 5-fluor-L-pipekolsyre-hydrobromid. A mixture of 2.2 g of 1-carbobenzyloxy-5-fluoro-L-pipecolic acid and 12 ml of hydrogen bromide in acetic acid (30-32%) is stirred for 30 minutes at room temperature, and then 300 ml of anhydrous ether is added. The cooled mixture is filtered and the precipitated solid is dried under reduced pressure to give 5-fluoro-L-pipecolic acid hydrobromide.

F) 1-[ D- 3-( acetyltio)- 2- metyl- l- oksopropyl]- 5- fluor-L- pipekolsyre F) 1-[ D- 3-( acetylthio)- 2- methyl- l- oxopropyl]- 5- fluoro-L-pipecolic acid

Til en suspensjon av 5,1 g 5-fluor-L-pipekolsyre-hydrobromid i 100 ml dimetylacetonid settes 10 g N-metylmorfolin. Til denne blanding settes derefter langsomt med kraftig omrøring ■ 5,4 g D-3-acetyl-2-metylpropionylklorid, og reaksjonsblandingen oppvarmes ved 90° i 3 timer. Den avkjølte reaksjonsblanding filtreres og konsentreres under redusert trykk. Residuet behandles med fortynnet saltsyre og ekstraheres med etylacetat (3 x 150 ml). Etylacetatekstraktene tørres og konsentreres derefter under redusert trykk for å gi 1-[D-3-(acetyltio)-2-metyl-l-oksopropyl]-5-fluor-L-pipekolsyre. 10 g of N-methylmorpholine are added to a suspension of 5.1 g of 5-fluoro-L-pipecolic acid hydrobromide in 100 ml of dimethylacetonide. 5.4 g of D-3-acetyl-2-methylpropionyl chloride are then slowly added to this mixture with vigorous stirring, and the reaction mixture is heated at 90° for 3 hours. The cooled reaction mixture is filtered and concentrated under reduced pressure. The residue is treated with dilute hydrochloric acid and extracted with ethyl acetate (3 x 150 ml). The ethyl acetate extracts are dried and then concentrated under reduced pressure to give 1-[D-3-(acetylthio)-2-methyl-1-oxopropyl]-5-fluoro-L-pipecolic acid.

Syren renses ved omdannelse til dicykloheksylaminsaltet fulgt av krystallisering av saltet fra acetonitril. The acid is purified by conversion to the dicyclohexylamine salt followed by crystallization of the salt from acetonitrile.

Eksempel 4 7 Example 4 7

5- f luor- 1- ( D- 3- merkapto- 2- metyl- l- oksopro. py 1) - L- pipekolsyre 5- f fluoro- 1- ( D- 3- mercapto- 2- methyl- l- oxopro. py 1) - L- pipecolic acid

Nitrogen bobles gjennom en oppløsning (5°) av 11 ml konsentrert ammoniumhydroksyd i 25 ml vann i 30 minutter. Til denne oppløsning settes 1,6 g 1-[D-3-(acetyltio)-2-metyl-l-oksopropyl ] -5-f luor-L-pipekolsyre , og blandingen omrøres i 15 minutter ved 5° og derefter i 4 timer ved romtemperatur. Nitrogen is bubbled through a solution (5°) of 11 ml of concentrated ammonium hydroxide in 25 ml of water for 30 minutes. 1.6 g of 1-[D-3-(acetylthio)-2-methyl-1-oxopropyl]-5-fluoro-L-pipecolic acid is added to this solution, and the mixture is stirred for 15 minutes at 5° and then for 4 hours at room temperature.

Oppløsningen avkjøles derefter, surgjøres med konsentrert saltsyre og ekstraheres med etylacetat (3 x 50 ml). Etylacetatekstraktene tørres over vannfritt magnesiumsulfat og konsentreres under redusert trykk for å gi 5-fluor-1-(D-3-merkapto-2-metyl-l-oksopropyl)-L-pipekolsyre. The solution is then cooled, acidified with concentrated hydrochloric acid and extracted with ethyl acetate (3 x 50 mL). The ethyl acetate extracts are dried over anhydrous magnesium sulfate and concentrated under reduced pressure to give 5-fluoro-1-(D-3-mercapto-2-methyl-1-oxopropyl)-L-pipecolic acid.

Eksempel 4 8 Example 4 8

1-( 3- merkapto- 2- trifluormetylpropanoyl)- L- pipekolsyre1-(3-mercapto-2-trifluoromethylpropanoyl)-L-pipecolic acid

Ved å anvende L-pipekolsyre-tert-butylester istedenfor L-prolin-tert-butylester ved fremgangsmåten ifølge eksempel 2, By using L-pipecolic acid tert-butyl ester instead of L-proline tert-butyl ester in the method according to example 2,

og underkaste produktet fremgangsmåtene ifølge eksempel 3 og 4, får man 1-(3-merkapto-2-trifluormetylpropanoy1-L-pipekolsyre. and subjecting the product to the methods according to examples 3 and 4, 1-(3-mercapto-2-trifluoromethylpropanoyl-1-L-pipecolic acid is obtained).

Eksempel 49Example 49

1-( 2- merkapto- 3, 3, 3- trifluorpropanoyl)- L- pipekolsyre1-( 2- mercapto- 3, 3, 3- trifluoropropanoyl)- L- pipecolic acid

Ved å anvende L-pipekolsyre.istedenfor L-prolin ved fremgangsmåten ifølge eksempel 7, og derefter underkaste produktet fremgangsmåten ifølge eksempel 8, får man 1-(2-merkapto-3,3,3-tri fluorpropanoyl)-L-pipekolsyre. By using L-pipecolic acid instead of L-proline in the method according to example 7, and then subjecting the product to the method according to example 8, 1-(2-mercapto-3,3,3-trifluoropropanoyl)-L-pipecolic acid is obtained.

Eksempel 50 Example 50

1-( 3- merkapto- 2- trifluormetylpropanoyl)- 5, 5- difluor- DL- pipekolsyre Ved å anvende 5,5-difluor-DL-pipekolsyre [erholdt fra 5-keto-DL-pipekolsyre ved fremgangsmåten beskrevet i J. Med. Chem. 20, 1176 (1977)] istedenfor 4,4-difluor-L-prolin ved fremgangsmåten ifølge eksempel 11 og underkaste produktet fremgangsmåten 1-(3-mercapto-2-trifluoromethylpropanoyl)-5,5-difluoro-DL-pipecolic acid Using 5,5-difluoro-DL-pipecolic acid [obtained from 5-keto-DL-pipecolic acid by the method described in J. Med . Chem. 20, 1176 (1977)] instead of 4,4-difluoro-L-proline by the method according to Example 11 and subjecting the product to the method

ifølge eksempel 12, får man 1-(3-merkapto-2-trifluormetylpropanoyl) -5 , 5-dif luor-DL-pipekolsyre . according to example 12, 1-(3-mercapto-2-trifluoromethylpropanoyl)-5,5-difluoro-DL-pipecolic acid is obtained.

Eksempel 51 Example 51

1, 1'-[ ditiobis-( 2- trifluormety1- 3- propanoyl)]- bis- 5, 5- difluor-DL- pipekolsyre 1, 1'-[ dithiobis-(2- trifluoromethyl- 3- propanoyl)]- bis- 5, 5- difluoro-DL-pipecolic acid

Ved å anvende 1-(3-merkapto-2-trifluormetylpropanoyl)-5,5-difluor-DL-pipekolsyre istedenfor 1-(3-merkapto-2-trifluormetylpropanoyl) -L-prolin ved fremgangsmåten ifølge eksempel 9, By using 1-(3-mercapto-2-trifluoromethylpropanoyl)-5,5-difluoro-DL-pipecolic acid instead of 1-(3-mercapto-2-trifluoromethylpropanoyl)-L-proline in the method according to Example 9,

får man 1,1'-[ditiobis-(2-trifluormety1-3-propanoyl)]-bis-5,5-difluor-DL-pipekolsyre. 1,1'-[dithiobis-(2-trifluoromethyl-3-propanoyl)]-bis-5,5-difluoro-DL-pipecolic acid is obtained.

Eksempel 5 2 Example 5 2

1- ( 3- merkapto- 4 , 4,, 4- trif luorbutanoyl) - L- pipekolsyre1-(3-mercapto-4,4,4-trifluorobutanoyl)-L-pipecolic acid

Ved å anvende L-pipekolsyre-tert.butylester istedenfor L-prolin-tert.butylester ved fremgangsmåten ifølge eksempel 14, By using L-pipecolic acid tert-butyl ester instead of L-proline tert-butyl ester in the method according to example 14,

og derefter underkaste produktet fremgangsmåten ifølge eksempel 15, får man 1-(3-merkapto-4,4,4-trifluorbutanoyl)-L-pipekolsyre. and then subjecting the product to the method according to example 15, 1-(3-mercapto-4,4,4-trifluorobutanoyl)-L-pipecolic acid is obtained.

Eksempel 5 3 Example 5 3

1-( 3- merkapto- 2- trifluormetylpropanoyl)- 5, 5- diklor- DL- pipekolsyre 1-( 3- mercapto- 2- trifluoromethylpropanoyl)- 5, 5- dichloro- DL-pipecolic acid

Ved å anvende 5,5-diklor-DL-pipekolsyre [fremstilt fra 5-keto-DL-pipekolsyre og fos forpentaklorid ved en fremgangsmåte lik den som er beskrevet i J. Med. Chem. 20, 1176 (1977)] By using 5,5-dichloro-DL-pipecolic acid [prepared from 5-keto-DL-pipecolic acid and phosphorus pentachloride by a method similar to that described in J. Med. Chem. 20, 1176 (1977)]

istedenfor 4,4-difluor-L-prolin ved fremgangsmåten ifølge eksempel 11 og derefter underkaste produktet fremgangsmåten ifølge eksempel 12, får man 1-(3-merkapto-2-trifluormetylpropanoyl)-5,5-diklor-DL-pipekolsyre . instead of 4,4-difluoro-L-proline in the method according to example 11 and then subjecting the product to the method according to example 12, 1-(3-mercapto-2-trifluoromethylpropanoyl)-5,5-dichloro-DL-pipecolic acid is obtained.

Eksempel 5 4 Example 5 4

1-( 3- merkapto- 2- metylpropanoyl)- 5, 5- difluor- DL- pipekolsyre1-( 3- mercapto- 2- methylpropanoyl)- 5, 5- difluoro- DL-pipecolic acid

Ved å anvende 3-acetyltio-2-metylpropansyreklorid istedenfor 3-acetyltio-2-trifluormetylpropansyreklorid ved fremgangsmåten ifølge eksempel 11, og derefter underkaste produktet fremgangsmåten ifølge eksempel 12, får man 1-(3-merkapto-2-metylpropanoyl)-5,5-difluor-DL-pipekolsyre. By using 3-acetylthio-2-methylpropanoic acid chloride instead of 3-acetylthio-2-trifluoromethylpropanoic acid chloride in the method according to example 11, and then subjecting the product to the method according to example 12, one obtains 1-(3-mercapto-2-methylpropanoyl)-5,5 -difluoro-DL-pipecolic acid.

Eksempel 55Example 55

1-( 3- merkapto- 2- metylpropanoyl)- 5- fluor- DL- pipekolsyre1-( 3- mercapto- 2- methylpropanoyl)- 5- fluoro- DL- pipecolic acid

Ved å anvende 3-acetyltio-2-metylpropansyreklorid istedenfor 3-acetyltio-2-trifluormetylpropansyreklorid og 5-fluor-DL-pipekolsyre .[fremstilt fra 5-hydroksypipekolsyre ved en fremgangsmåte lik den som er beskrevet i Biochemistry, 4, 2507 (1965)] istedenfor 4,4-difluor-L-prolin ved fremgangsmåten ifølge eksempel 11, og derefter underkaste produktet fremgangsmåten ifølge eksempel 12, får man 1-(3-acetyltio-2-metylpropanoyl)-5-fluor-DL-pipekolsyre og 1-(3-merkapto-2-metylpropanoyl)-5-fluor-DL-pipekolsyre . By using 3-acetylthio-2-methylpropanoic acid chloride instead of 3-acetylthio-2-trifluoromethylpropanoic acid chloride and 5-fluoro-DL-pipecolic acid .[prepared from 5-hydroxypipecolic acid by a method similar to that described in Biochemistry, 4, 2507 (1965) ] instead of 4,4-difluoro-L-proline by the method according to example 11, and then subjecting the product to the method according to example 12, one obtains 1-(3-acetylthio-2-methylpropanoyl)-5-fluoro-DL-pipecolic acid and 1- (3-Mercapto-2-methylpropanoyl)-5-fluoro-DL-pipecolic acid.

Eksempel 56Example 56

1-( 3- merkaptopropanoyl)- 5- brom- DL- pipekolsyre1-(3-mercaptopropanoyl)-5-bromo-DL-pipecolic acid

Ved å anvende 3-acetyltippropanoylklorid istedenfor 3-acetyltio-2-trifluormetylpropansyreklorid og 5-brom-DL-pipekolsyre [fremstilt fra 5-hydroksypipekolsyre ved en fremgangsmåte lik den som er beskrevet i Aust. J. Chem. 2_0, 149 3 (196 7)] istedenfor 4,4-difluor-L-prolin ved fremgangsmåten ifølge eksempel 11, og underkaste produktet fremgangsmåten ifølge eksempel 12, får man 1-(3-acetyltiopropanoyl)-5-brom-DL-pipekolsyre og 1-(3-merkaptopropanoyl)-5-brom-DL-pipekolsyre. By using 3-acetyltippropanoyl chloride instead of 3-acetylthio-2-trifluoromethylpropanoic acid chloride and 5-bromo-DL-pipecolic acid [prepared from 5-hydroxypipecolic acid by a method similar to that described in Aust. J. Chem. 2_0, 149 3 (196 7)] instead of 4,4-difluoro-L-proline in the method according to example 11, and subjecting the product to the method according to example 12, one obtains 1-(3-acetylthiopropanoyl)-5-bromo-DL-pipecolic acid and 1-(3-mercaptopropanoyl)-5-bromo-DL-pipecolic acid.

Eksempel 57 Example 57

1-( 3- acetyltio- 2- tri fluormetylpropanoyl)- DL- pipekoIsyre- metylester 1-( 3- acetylthio- 2- trifluoromethylpropanoyl)- DL- pipecoI acid methyl ester

Ved å anvende DL-pipekolsyre-metylester istedenfor L-prolin-tert.butylester ved fremgangsmåten ifølge eksempel 2 får man 1-(3-acetyltio-2-trifluormetylpropanoyl)-DL-pipekolsyre-metylester. By using DL-pipecolic acid methyl ester instead of L-proline tert-butyl ester in the method according to example 2, 1-(3-acetylthio-2-trifluoromethylpropanoyl)-DL-pipecolic acid methyl ester is obtained.

Eksempel 5 8 Example 5 8

1-( 3- merkapto- 2- trifluormetylpropanoyl- DL- pipekolsyre- metylester 1-( 3- mercapto- 2- trifluoromethylpropanoyl- DL-pipecolic acid- methyl ester

Ved å anvende DL-pipekolsyre-metylester istedenfor L-prolin-tert-butylester og 3-merkapto-2-trifluormetylpropansyre istedenfor 3-acetyltio-2-metylpropansyre ved fremgangsmåten ifølge eksempel 2, får man 1-(3-merkapto-2-trifluormetylpropanoyl)-DL-pipekolsyre-metylester. By using DL-pipecolic acid methyl ester instead of L-proline tert-butyl ester and 3-mercapto-2-trifluoromethylpropanoyl instead of 3-acetylthio-2-methylpropanoic acid in the method according to example 2, 1-(3-mercapto-2-trifluoromethylpropanoyl) is obtained )-DL-pipecolic acid methyl ester.

Eksempel 59 Example 59

1- ( 3- propanoylt' io- 2 - tri f luormetylpropanoyl) - 5- f luor- DL- pipekolsyre 1-(3-propanoyl'io-2-trifluoromethylpropanoyl)-5-fluoro-DL-pipecolic acid

Ved å anvende tiopropansyre istedenfor tioleddiksyre ved fremgangsmåten ifølge eksempel 1 og derefter underkaste produktet fremgangsmåten ifølge eksempel 26, får man 1-(3-propanoyltio-2-trifluormetylpropanoyl)-5-fluor-DL-pipekolsyre. By using thiopropanoic acid instead of thioacetic acid in the method according to example 1 and then subjecting the product to the method according to example 26, 1-(3-propanoylthio-2-trifluoromethylpropanoyl)-5-fluoro-DL-pipecolic acid is obtained.

Eksempel 60 Example 60

1-( 3- merkapto- 2- metylpropanoy1)- 5- fluor- DL- pipekolsyre- natriumsalt 1-( 3- mercapto- 2- methylpropanoy1)- 5- fluoro- DL- pipecolic acid sodium salt

En vandig oppløsning av 1-(3-merkapto-2-mety1-propanoy1)-5-fluor-DL-pipekolsyre blandes med en ekvimolar mengde vandig N natriumhydroksyd, og oppløsningen frysetrørres. An aqueous solution of 1-(3-mercapto-2-methyl-propanoyl)-5-fluoro-DL-pipecolic acid is mixed with an equimolar amount of aqueous N sodium hydroxide, and the solution is freeze-stirred.

Eksempel 61Example 61

1-( 3- merkaptopropanoyl)- 5, 5- diklor- DL- pipekolsyre1-( 3- mercaptopropanoyl)- 5, 5- dichloro- DL-pipecolic acid

Ved å anvende 3-acetyltiopropansyreklorid istedenfor 3-acetyltio-2-trifluormetylpropansyreklorid ved fremgangsmåten ifølge eksempel 53, får man 1-(3-merkaptopropanoyl)-5,5-diklor-DL-pipekolsyre . By using 3-acetylthiopropanoic acid chloride instead of 3-acetylthio-2-trifluoromethylpropanoic acid chloride in the method according to example 53, 1-(3-mercaptopropanoyl)-5,5-dichloro-DL-pipecolic acid is obtained.

De racemiske former for sluttproduktene i hvert av de foregående eksempler oppnås ved å anvende DL-formen av utgangs-aminosyren istedenfor L-formen. The racemic forms of the final products in each of the preceding examples are obtained by using the DL form of the starting amino acid instead of the L form.

Tilsvarende dannes D-formen av sluttproduktene i hvert av de foregående eksempler ved å anvende D-formen av utgangs-aminosyren istedenfor L-formen. Correspondingly, the D form of the final products is formed in each of the previous examples by using the D form of the starting amino acid instead of the L form.

Claims (22)

1. Fremgangsmåte for fremstilling av forbindelser med den generelle formel(I) 1. Process for the preparation of compounds of the general formula (I) hvor R er hydrogen, lavere alkanoyl eller where R is hydrogen, lower alkanoyl or m er 1 eller 2; n er 0 eller 1; R^ er hydrogen eller lavere alkyl; og R'2 er hver hydrogen eller halogen; R^ er hydrogen, lavere alkyl eller CF^ , og også halogen når n er 1; R^ er hydrogen, lavere alkyl eller trifluormetyl; Rg er hydrogen, og også halogen når m er 1; idet minst én avR^ , R'2 , R^ , R^ og R^ er halogen eller CF ^ som representert ved symbolene, og bare R2 og R'2 kan begge være halogen samtidig, og basiske salter derav, karakterisert ved at en syre med formelen m is 1 or 2; n is 0 or 1; R 1 is hydrogen or lower alkyl; and R' 2 is each hydrogen or halogen; R 2 is hydrogen, lower alkyl or CF 2 , and also halogen when n is 1; R 1 is hydrogen, lower alkyl or trifluoromethyl; Rg is hydrogen, and also halogen when m is 1; wherein at least one of R^ , R'2 , R^ , R^ and R^ is halogen or CF^ as represented by the symbols, and only R2 and R'2 can both be halogen at the same time, and basic salts thereof, characterized in that an acid with the formula kobles til en aminosyre med formelen:- hvor R er hydrogen eller lavere alkanoyl eller en p-metoksybenzy1-beskyttende gruppe som fjernes senere; og de andre grupper er som angitt ovenfor, for å danne et produkt hvor R ér hydrogen eller lavere alkanoyl, og eventuelt oksyderes nevnte produkt hvor R er hydrogen, ved behandling med jod, for å danne et produkt . hvor R er is linked to an amino acid of the formula:- where R is hydrogen or lower alkanoyl or a p-methoxybenzy1 protecting group which is subsequently removed; and the other groups are as indicated above, to form a product where R is hydrogen or lower alkanoyl, and optionally said product where R is hydrogen is oxidized, by treatment with iodine, to form a product. where R is 2. Fremgangsmåte som angitt i krav 1, karakterisert ved at produktet hvor R er lavere alkanoyl, hydrolyseres for å danne ét produkt hvor R er hydrogen. 2. Method as stated in claim 1, characterized in that the product where R is lower alkanoyl is hydrolysed to form one product where R is hydrogen. 3. Fremgangsmåte som angitt i krav 2, karakterisert ved at et produkt hvor R er lavere alkanoyl, underkastes ammonolyse.3. Method as stated in claim 2, characterized in that a product where R is lower alkanoyl is subjected to ammonolysis. 4. Fremgangsmåte for fremstilling av forbindelser med den i krav 1 angitte formel, og basiske salter derav, karakterisert ved at en syre med formelen kobles til en halogenalkansyre med formelen hvor X er halogen og de andre symboler er som definert-ovenfor, for å danne en forbindelse med formelen 4. Process for the preparation of compounds with the formula stated in claim 1, and basic salts thereof, characterized in that an acid with the formula is coupled to a haloalkane acid with the formula where X is halogen and the other symbols are as defined above, to form a connection with the formula som omsettes videre med en tiosyre med formelen which is further reacted with a thioacid with the formula hvor R-, er lavere alkyl, for å danne et produkt hvor R er lavere alkanoyl, og eventuelt underkastes dette produkt hydrolyse for å danne et produkt hvor R er hydrogen, og eventuelt oksyderes dette produkt ved behandling med jod for å danne et produkt hvor R er where R-, is lower alkyl, to form a product where R is lower alkanoyl, and optionally this product is subjected to hydrolysis to form a product where R is hydrogen, and optionally this product is oxidized by treatment with iodine to form a product where R is 5. Fremgangsmåte for fremstilling av forbindelser med den i krav 1 angitte formel, og basiske salter derav, karakterisert ved at en forbindelse med formelen 5. Process for the preparation of compounds with the formula specified in claim 1, and basic salts thereof, characterized in that a compound with the formula hvor symbolene er som ovenfor angitt, omsettes med en forbindelse med formelen R^ -CO-SH hvor R? er lavere alkyl, for å danne et produkt hvor R er lavere alkanoyl, og eventuelt hydrolyseres dette produkt for å danne et produkt hvor R er hydrogen, og eventuelt behandles dette produkt hvor R er hydrogen med jod for å danne et produkt hvor R erwhere the symbols are as indicated above, is reacted with a compound of the formula R^ -CO-SH where R? is lower alkyl, to form a product where R is lower alkanoyl, and optionally this product is hydrolyzed to form a product where R is hydrogen, and optionally this product where R is hydrogen is treated with iodine to form a product where R is 6. Fremgangsmåte som angitt i krav 1 til 5, karakterisert ved at produktet har formelen 6. Method as stated in claims 1 to 5, characterized in that the product has the formula hvor R er hydrogenlavere alkanoyl eller where R is hydrogen lower alkanoyl or R^ er hydrogen eller lavere alkyl; , R <1>2°9 Rg er hver hydrogen eller halogen; R^ er hydrogen, lavere alkyl, halogen eller trifluormety1; R^ er hydrogen, lavere alkyl eller trifluormetyl; med det forbehold at minst én av R2 , R^ , R^ , R^ og Rg er en halogensubstituent representert ved symbolene, bare.R2 og R^ kan begge være halogen, og når R^ er halogen, må n være 1; og basiske salter derav, iR 1 is hydrogen or lower alkyl; , R<1>2°9 Rg is each hydrogen or halogen; R 1 is hydrogen, lower alkyl, halogen or trifluoromethyl; R 1 is hydrogen, lower alkyl or trifluoromethyl; with the proviso that at least one of R2 , R^ , R^ , R^ and Rg is a halogen substituent represented by the symbols, only. R2 and R^ may both be halogen, and when R^ is halogen, n must be 1; and basic salts thereof, in 7. Fremgangsmåte som angitt i krav 1 til 5, karakterisert ved at produktet har formelen hvor R er hydrogen, lavere alkanoyl eller R1 er hydrogen eller lavere alkyl; R2 og R,, er hver hydrogen eller fluor; R3 og R^ er hver hydrogen eller trifluormetyl, idet en er hydrogen og den annen trifluormetyl, og basiske salter derav.7. Process as stated in claims 1 to 5, characterized in that the product has the formula where R is hydrogen, lower alkanoyl or R1 is hydrogen or lower alkyl; R 2 and R 1 are each hydrogen or fluorine; R 3 and R 3 are each hydrogen or trifluoromethyl, one being hydrogen and the other trifluoromethyl, and basic salts thereof. 8. Fremgangsmåte som angitt i krav 1 til-5, karakterisert ved at produktet har formelen 8. Method as stated in claims 1 to 5, characterized in that the product has the formula hvor R er hydrogen, lavere alkanoyl eller where R is hydrogen, lower alkanoyl or R^ er hydrogen eller lavere alkyl; R^ og Rj. er hver hydrogen eller fluor; R^ er hydrogen, halogen eller lavere alkyl; idet R^ er halogen når både R,, og R<_ er hydrogen, og R^ er forskjellig fra halogen når R2 eller R^ er halogen; og R^ er hydrogen, og basiske salter derav.R 1 is hydrogen or lower alkyl; R^ and Rj. is each hydrogen or fluorine; R 1 is hydrogen, halogen or lower alkyl; wherein R 1 is halogen when both R 1 and R 1 are hydrogen, and R 1 is different from halogen when R 2 or R 1 is halogen; and R^ is hydrogen, and basic salts thereof. 9. Fremgangsmåte som angitt i krav 1 til 5, karakterisert ved at R er hydrogen eller lavere alkanoyl; R^ er hydrogen eller lavere alkyl; og R'2 er hydrogen eller halogen; R^ er hydrogen eller lavere alkyl; og R^ er hydrogen eller lavere alkyl.9. Process as stated in claims 1 to 5, characterized in that R is hydrogen or lower alkanoyl; R 1 is hydrogen or lower alkyl; and R' 2 is hydrogen or halogen; R 1 is hydrogen or lower alkyl; and R 1 is hydrogen or lower alkyl. 10. Fremgangsmåte som angitt i krav 1 til 5, karakterisert ved at R er hydrogen eller lavere alkanoyl; R^ er hydrogen eller lavere alkyl; og R'2 er hver hydrogen eller fluor; R^ er hydrogen eller lavere alkyl og R^ er hydrogen eller lavere alkyl.10. Method as stated in claims 1 to 5, characterized in that R is hydrogen or lower alkanoyl; R 1 is hydrogen or lower alkyl; and R' 2 is each hydrogen or fluorine; R 1 is hydrogen or lower alkyl and R 2 is hydrogen or lower alkyl. 11. Fremgangsmåte som angitt i krav 1 til 5, karakterisert ved at R er hydrogen og R2 og R'2 er hver fluor.11. Method as stated in claims 1 to 5, characterized in that R is hydrogen and R 2 and R' 2 are each fluorine. 12. Fremgangsmåte som angitt i krav 1 til 5, karakterisert ved at R og R^ hver er hydrogen, R2 og R <1>2 hver er fluor og R^ og R^ hver er hydrogen eller lavere alkyl.12. Process as stated in claims 1 to 5, characterized in that R and R^ are each hydrogen, R 2 and R < 1> 2 are each fluorine and R 1 and R 2 are each hydrogen or lower alkyl. 13. Fremgangsmåte som angitt i krav 8, karakterisert ved at er hydrogen eller fluor, Rj. er fluor, R er hydrogen og R^ , R^ og R^ hver er hydrogen eller lavere alkyl.13. Method as stated in claim 8, characterized in that is hydrogen or fluorine, Rj. is fluorine, R is hydrogen and R 1 , R 2 and R 3 are each hydrogen or lower alkyl. 14. Fremgangsmåte som angitt i krav 8, karakterisert ved at R^ er hydrogen, R,- er fluor, R er hydrogen og R^, R^ og R^ hver er hydrogen eller lavere alkyl.14. Process as set forth in claim 8, characterized in that R^ is hydrogen, R^- is fluorine, R is hydrogen and R^, R^ and R^ are each hydrogen or lower alkyl. 15. Fremgangsmåte som angitt i krav 13 og 14, karakterisert ved at R, og hver er hydrogen og R^ er metyl.15. Method as stated in claims 13 and 14, characterized in that R, and each is hydrogen and R^ is methyl. 16. Fremgangsmåte som angitt i krav 1 til 5, karakterisert ved at produktet har formelen hvor R er hydrogen, lavere alkanoyl eller m er 2,16. Process as stated in claims 1 to 5, characterized in that the product has the formula where R is hydrogen, lower alkanoyl or m is 2, 1*2 er hydrogen eller lavere alkyl;;1*2 og R'2 er hver hydrogen eller halogen; R3 og R^ er hver hydrogen, lavere alkyl eller trifluormetyl, idet ikke mer enn én av dem er trifluormety1, og minst én av R^ , ^'2' R3 °^ ^4 er en nal°cfensubstituent representert ved symbolet; og basiske salter derav.1*2 is hydrogen or lower alkyl;; 1*2 and R'2 are each hydrogen or halogen; R3 and R3 are each hydrogen, lower alkyl or trifluoromethyl, no more than one of which is trifluoromethyl, and at least one of R^, ^'2' R3 °^ ^4 is a nal°cphene substituent represented by the symbol; and basic salts thereof. 17. Fremgangsmåte som angitt i krav 16, karakterisert ved at R, R^ , og alle er hydrogen, og R^ er trifluormetyl.17. Process as set forth in claim 16, characterized in that R, R^, and are all hydrogen, and R^ is trifluoromethyl. 18. Fremgangsmåte som angitt i krav 16, karakterisert ved at. R2 er halogen og R'2 er hydrogen.18. Method as specified in claim 16, characterized in that. R2 is halogen and R'2 is hydrogen. 19. Fremgangsmåte som angitt i krav 18, karakterisert ved at halogenet er fluor.19. Method as stated in claim 18, characterized in that the halogen is fluorine. 20. Fremgangsmåte som angitt i krav 16, karakterisert ved at R er hydrogen og R2 og R'2 er hver halogen.20. Method as stated in claim 16, characterized in that R is hydrogen and R 2 and R' 2 are each halogen. 21. Fremgangsmåte som angitt i krav 20, karakterisert ved at halogenet er fluor.21. Method as stated in claim 20, characterized in that the halogen is fluorine. 22. Fremgangsmåte som angitt i krav 16, karakterisert ved at R og R^ er hydrogen, R2 er hydrogen eller fluor, R'2 er fluor, R^ er metyl, R^ er hydrogen og n er 1.22. Method as stated in claim 16, characterized in that R and R^ are hydrogen, R2 is hydrogen or fluorine, R'2 is fluorine, R^ is methyl, R^ is hydrogen and n is 1.
NO790568A 1978-02-21 1979-02-20 PROCEDURE FOR THE PREPARATION OF HALOGEN-SUBSTITUTED MARKAPTOACYLAMINO ACIDS NO790568L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87903278A 1978-02-21 1978-02-21
US93914878A 1978-09-01 1978-09-01
US05/939,147 US4154935A (en) 1978-02-21 1978-09-01 Halogen substituted mercaptoacylamino acids

Publications (1)

Publication Number Publication Date
NO790568L true NO790568L (en) 1979-08-22

Family

ID=27420501

Family Applications (1)

Application Number Title Priority Date Filing Date
NO790568A NO790568L (en) 1978-02-21 1979-02-20 PROCEDURE FOR THE PREPARATION OF HALOGEN-SUBSTITUTED MARKAPTOACYLAMINO ACIDS

Country Status (26)

Country Link
JP (1) JPS54125656A (en)
AR (2) AR229152A1 (en)
CA (1) CA1124723A (en)
CH (1) CH639370A5 (en)
CS (1) CS230562B2 (en)
DD (1) DD141827A5 (en)
DE (1) DE2906768A1 (en)
DK (1) DK73379A (en)
ES (3) ES477878A1 (en)
FI (1) FI790593A (en)
FR (1) FR2417499A1 (en)
GB (1) GB2014987B (en)
GR (1) GR82336B (en)
HK (1) HK41383A (en)
IE (1) IE47971B1 (en)
IL (1) IL56662A0 (en)
LU (1) LU80946A1 (en)
NL (1) NL7901319A (en)
NO (1) NO790568L (en)
NZ (1) NZ189626A (en)
PH (1) PH15381A (en)
PL (1) PL118158B1 (en)
PT (1) PT69254A (en)
RO (1) RO77228A (en)
SE (1) SE431643B (en)
SU (1) SU882409A3 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1144930A (en) * 1978-08-11 1983-04-19 Miguel A. Ondetti Mercaptoacyl derivatives of substituted prolines
NL7809120A (en) * 1978-09-07 1980-03-11 Oce Andeno B V Grubbenvorsterw PROCESS FOR THE PREPARATION OF PROLINE DERIVATIVES.
US4483861A (en) * 1978-10-31 1984-11-20 Santen Pharmaceutical Co., Ltd. Antihypertensive sulfur-containing compounds
CA1132985A (en) * 1978-12-22 1982-10-05 John Krapcho Ketal and thioketal derivatives of mercaptoacyl prolines
ZA802420B (en) * 1979-05-18 1981-04-29 Squibb & Sons Inc Aminoacyl derivatives of mercaptoacyl amino acids
US4288368A (en) * 1979-07-30 1981-09-08 E. R. Squibb & Sons, Inc. Dithioacylproline derivatives
AU542211B2 (en) * 1980-03-07 1985-02-14 Gruppo Lepetit S.P.A. Mercaptocycloalkyl carbonyl prolines
JP2005213165A (en) * 2004-01-28 2005-08-11 Mitsui Chemicals Inc Method for producing fluoroproline compounds
JP2011121872A (en) * 2009-12-08 2011-06-23 Central Glass Co Ltd Method for purifying optically active n-tert-butoxycarbonyl-trans-4-fluoroproline

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU509899B2 (en) * 1976-02-13 1980-05-29 E.R. Squibb & Sons, Inc. Proline derivatives and related compounds

Also Published As

Publication number Publication date
AR229152A1 (en) 1983-06-30
JPS54125656A (en) 1979-09-29
ES479833A1 (en) 1979-11-16
GB2014987A (en) 1979-09-05
PL118158B1 (en) 1981-09-30
NZ189626A (en) 1982-03-09
ES477878A1 (en) 1980-03-01
FR2417499B1 (en) 1982-06-04
CS230562B2 (en) 1984-08-13
PL213593A1 (en) 1980-02-25
GR82336B (en) 1984-12-13
IL56662A0 (en) 1979-05-31
DD141827A5 (en) 1980-05-21
HK41383A (en) 1983-10-21
IE47971B1 (en) 1984-08-08
LU80946A1 (en) 1979-06-18
SE7901510L (en) 1979-08-22
CA1124723A (en) 1982-06-01
SU882409A3 (en) 1981-11-15
RO77228A (en) 1981-08-17
PT69254A (en) 1979-03-01
ES479832A1 (en) 1979-11-16
DE2906768A1 (en) 1979-08-23
SE431643B (en) 1984-02-20
IE790297L (en) 1979-08-21
GB2014987B (en) 1982-11-03
JPH0134986B2 (en) 1989-07-21
FI790593A (en) 1979-08-22
CH639370A5 (en) 1983-11-15
NL7901319A (en) 1979-08-23
AR228036A1 (en) 1983-01-14
FR2417499A1 (en) 1979-09-14
DK73379A (en) 1979-08-22
PH15381A (en) 1982-12-17

Similar Documents

Publication Publication Date Title
US4154935A (en) Halogen substituted mercaptoacylamino acids
US4046889A (en) Azetidine-2-carboxylic acid derivatives
US4129566A (en) Derivatives of dehydrocyclicimino acids
US4128653A (en) Reduction of blood pressure with carboxyalkylacyl-pipecolic acid derivatives
US4316906A (en) Mercaptoacyl derivatives of substituted prolines
US4692458A (en) Anti-hypertensive agents
NO781392L (en) MARKAPTOALKYLSYLPHONYL-PROLIN DERIVATIVES AND RELATED COMPOSITIONS
NO146985B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE PROLIN-AZETIDINE AND PIPERIDINE DERIVATIVES
US4296113A (en) Mercaptoacyl derivatives of keto substituted proline and pipecolic acid
US4154937A (en) Hydroxycarbamoylalkylacylpipecolic acid compounds
NO153569B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE BRAND CAPACETYL-PROLIN DERIVATIVES.
US4296033A (en) 4-Azido-1-mercaptoacyl proline
US4241076A (en) Halogenated substituted mercaptoacylamino acids
NO790568L (en) PROCEDURE FOR THE PREPARATION OF HALOGEN-SUBSTITUTED MARKAPTOACYLAMINO ACIDS
CA1124726A (en) Derivatives of pyrrolidinecarboxaldehyde and piperidinecarboxaldehyde and intermediates therefor
US4181663A (en) Selenium containing derivatives of proline and pipecolic acid
US4833152A (en) Anti-hypertensive agents
US4690936A (en) Anti-hypertensive agents
US4330548A (en) Mercaptoacyl derivatives of keto substituted pipecolic acid
CA1103255A (en) Proline derivatives and related compounds
US4308388A (en) 4-Azido-1-mercaptoacyl pipecolic acid
EP0042639A2 (en) Azido, imido, amido and amino derivatives of mercaptoacyl prolines and pipecolic acids having hypotensive activity
KR820001832B1 (en) Process for preparing halogen substituted mercaptoacylamino acids
NO800620L (en) PROCEDURE FOR THE PREPARATION OF PROLINIC AND PIPE CARBIC ACID DERIVATIVES.
CA1138878A (en) Mercaptoacyl derivatives of keto substituted proline and pipecolic acid